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Diatoms are unicellular photosynthetic algae that display intricately patterned cell 
walls made of amorphous silicon dioxide (silica). Long-chain polyamines and highly 
phosphorylated proteins, silaffins and silacidins, are believed to play an important role in 
biosilica formation.  The phosphate moieties on silaffins and silacidins play a significant 
role in biomineral formation, yet no kinase has been identified that phosphorylates these 
biomineral forming proteins. This dissertation describes the characterization of a novel 
kinase from the diatom Thalassiosira pseudonana, tpSTK1, which is upregulated during 
silica formation. A recombinantly expressed histidine-tagged version of tpSTK1 was 
capable of phosphorylating recombinant silaffins but not recombinant silacidin in vitro. 
Through establishing methods for subcellular fraction of T. pseudonana membranes in 
combination with antibody inhibition assay, it was discovered that native tpSTK1 
phosphorylates silaffins but not silacidins in vitro (i.e. it exhibits the same substrate 
specificity as recombinant tpSTK1). As tpSTK1 is an abundant protein in the ER lumen 
(~ 0.5 % of total ER protein) it seems highly likely to function as a silaffin kinase in vivo. 
TpSTK1 lacks clear sequence homologs in non-diatom organisms and is the first 
molecularly characterized kinase that appears to be involved in biomineralization.  
 The predicted kinase domain (KD) of tpSTK2, the only T. pseudonana homolog 
of tpSTK1, was recombinantly expressed and tested for phosphorylation activity. 
Recombinant tpSTK2-KD and native tpSTK2 exhibited detectable activity with myelin 
basic protein, but did not phosphorylate silaffins or silacidins in vitro. Western blot 
analysis demonstrated that native tpSTK2 was not present in the ER, but associated with 




CHAPTER 1: INTRODUCTION 
 
1.1 Overview of Biomineralization 
 
 Understanding how living organisms synthesize inorganic substances mediated by 
organic molecules in a process called biomineralization has intrigued scientists for 
hundreds of years. A wide range of organisms, from bacteria to humans, produce a 
variety of inorganic materials such as iron oxide, calcium carbonates, calcium 
phosphates, and silicates. The “biocomposites” (the term for the combination of organic 
material and minerals
1
) formed by these organisms exhibit complex, species-specific 


















, and silicon dioxide (SiO2)
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crystals. Bottom, Biocomposite formation of cococoliths by the phytoplankton Emiliania 
huxleyi 
5 
(left), bones in humans
6
 (center), and cell walls in a radiolaria
7
 (right) using the 





 The biologically mediated formation of these highly ordered, intricately structured 
biocomposites at ambient conditions is of great interest for materials scientists, who are 
often unable to synthesize complex chemical structures. Synthetic reproduction of these 
biocomposites would require identification of the key components involved in each stage 
of biomineralization: nucleation, organic matrix formation, and crystal growth 
regulation
8
. Although the biocomposites vary in their chemical composition, structures, 
and function, there are some similarities in their biomineralization processes. In all of the 
organisms studied to date, biomineral formation and morphogenesis occurs within 
specialized extra- or intracellular compartments mediated by a matrix of macromolecules 
that includes proteins and polysaccharides
1,8
.  Specifically, acidic phosphoproteins have 
been identified in organic matrices from a diverse set of biominerals (from marine algae 
to humans) and that may interact with mineral ions or the structural framework of the 
matrices
1,8-10
. In the following, several well characterized phosphoproteins involved in 
the formation of the most abundant biominerals (calcium carbonate, hydroxyapatite, and 
silica) will be discussed.  
 
1.2 Phosphoproteins Involved in Biomineralization 
 
1.2.1 Calcium Carbonate and Calcium Phosphate Biomineral Proteins 
 Comprising nearly 50 % of all known biominerals, calcium-containing minerals 
are the most abundant biominerals on Earth
8-9
. Due to the predominance of calcium-
containing biominerals, the field of biomineralization used to be known as “calcification” 






phosphate in the form of hydroxyapatite (Ca10(PO4)6(OH)2) and calcium carbonate 




1.2.1.1 Hydroxyapatite formation 
 Bone and dentin are mineralized tissues found in vertebrates that contain 
hydroxyapatite as the mineral component. The mineralization of bone (osteogenesis) and 
teeth (dentiogenesis) is a highly controlled process that occurs by the deposition of 
hydroxyapatite crystals (Ca10(PO4)6(OH)2) in an extracellular organic matrix consisting 
of type I collagen and several non-collagenous proteins (NCPs)
12
. Collagen serves as the 
structural framework of the organic matrices from bone and teeth and its mineralization is 
mediated by NCPs that are believed to induce and control hydroxyapatite formation
12
. 
Among the NCPs are the bone matrix proteins osteopontin (OP) and bone sialoprotein 
(BSP), and the dentin matrix protein phosphophoryn (PP) that belong to the SIBLING 
family (small integrin binding ligand N-linked glycoprotein). Although there is little 
sequence homology amongst the proteins in this family, they do share similar features: 1) 
presence of an Arg-Gly-Asp (RGD) motif that mediates cell attachment via its interaction 
with integrins, 2) prevalence of acidic amino acids (i.e. glutamate and/or aspartate), and 
3) modifications by posttranslational processing
12
. It has been demonstrated that the 
activities of OPN, BSP, and PP are influenced by their degree of phosphorylation.  
 In the process of bone remodeling, mature bone is removed (bone resorption) by 
osteoclasts and replaced with new bone (ossification) by osteoblasts. During bone 
remodeling, bone cells deposit various hypo-phosphorylated forms of the bone matrix 






suggesting that the degree of phosphorylation of these proteins is important in bone 
remodeling
14-18
. It has been demonstrated in vitro that the binding of bone cells to OPN 
and BSP (primarily achieved through the interactions of bone cell surface integrins with 
an RGD motif) can be enhanced by 40 % depending on the degree of phosphorylation of 
OPN and BSP
19-20
. In addition to bone cell attachment, BSP and OPN also regulate the 
bone mineralization process by acting as a nucleator or inhibitor, respectively, of 
hydroxyapatite formation. These activities are completely dependent on the 
phosphorylation level of the bone matrix proteins
21-26
. Knockout mice lacking OPN or 
BSP resulted in excessive mineralization of bone or stunted and demineralized bone, 




 OPN and BSP are also found in dentin but not as the predominant proteins
29
. 
Instead, dentin sialoprotein (DSP) and dentin phosphoprotein (also known as 
phosphophoryn, PP) and are the major NCPs found in dentin
12,29-31
. PP is the most 
abundant protein in the dentin extracellular organic matrix and is likely a key regulator of 
hydroxyapatite formation
12,29,31
. Mainly composed of aspartate and phosphoserine (~90 
% of all residues), phosphophoryn (PP) is a highly acidic phosphoprotein with a strong 
affinity for calcium ions
12,25,31-34
. The potency of calcium ion sequestering by PP has been 
attributed to the presence of phosphoserine as phosphorylated PP binds at least 2 fold 
more calcium than recombinant PP in vitro
32
. The phosphate moieties on PP are also 
responsible for the binding of PP to collagen fibrils, and the nucleation of hydroxyapatite 
crystals onto these fibrils as dephosphorylation of PP completely abolishes these 
activities in vitro
33-34




same inactive precursor protein, dentin sialophosphoprotein (DSPP), which is secreted by 
odontoblasts (tooth cells) and proteolytically processed to yield the two dentin NCPs
35
.  
Mutations in the Dspp gene or knockdown of the gene results in dentiogenesis imperfecta 
in humans or defective mineralization in mice, respectively, indicating that DSP and PP, 




1.2.1.2 Calcium carbonate formation 
 The most abundant biomineral produced is calcium carbonate (CaCO3), which is 
synthesized by a very large and diverse set of organisms
1,8-11
. The calcareous structures 
produced by these organisms primarily serve as an exoskeleton for protection or for the 
storage of calcium in terrestrial species where calcium availability is limited
11
. 
Depending on the specific function, these organisms are capable of utilizing one or more 
of the eight known polymorphs of CaCO3 for biomineralization, with the majority of 
species favoring calcite, aragonite, and amorphous CaCO3
1,8-11
.  
 As with hydroxyapatite mineralization, an organic matrix (consisting mainly of 
chitin) is secreted during calcium carbonate formation that is believed to control mineral 
formation and influence the crystal phase
8-9,11
. The organic matrix is typically divided 
into two classes based on its solubility after decalcification with EDTA or a weak acid: 
the soluble matrix and the insoluble matrix
8-9,11
. Generally, the soluble matrix is believed 
to interact with the mineral phase and is composed mainly of acidic amino acids (i.e. 
glutamate and aspartate), glycine, and phosphoserine that are believed to interact with the 
mineral
38-39
. In contrast, the insoluble matrix is thought to form the structural framework 







 Several soluble matrix proteins, specifically phosphoproteins, from some of the 
most highly studied calcium carbonate forming organisms (mollusks, crustaceans, and the 
sea urchin) have been characterized and are likely involved in calcium carbonate 
biomineralization
40-47
. Terrestrial crustaceans such as Orchestria cavimana and Cherax 
quadricarinatus store calcium (originating from the old calcified exoskeleton) in organs 
known as gastroliths as “concretions” composed of amorphous calcium carbonate 
precipitated within an organic matrix
40-41
. Two highly acidic phosphoproteins, orchestin 
and gastrolith protein-10 (GAP-10), identified in the organic matrices of the crustaceans’ 
concretions exhibit calcium binding activity in vitro
40-41
. For orchestin, it has been shown 
that phosphorylation of serine residues is required for its calcium binding activity
41
. The 
importance of protein phosphorylation of some soluble matrix proteins from molluscan 
and crustacean exoskeletons has also been demonstrated. Two highly acidic 
phosphoproteins from mollusk shells (RP-1; from the scallops Adamussium colbecki and 
the oyster Crassostrea virginica  and molluscan phosphorylated-protein (MPP-1); from 
the oyster Crassostrea nippona), and phosphoprotein calcification-associated peptide-1 
(CAP-1) from the cuticle ( term for crustacean exoskeleton) of the crayfish Procambarus 
clarkii all inhibit calcium carbonate precipitation in vitro due to their phosphate 
moieties
42-45
. Although the majority of these phosphoproteins from the soluble organic 
matrix play an inhibitor role in calcium carbonate crystal formation, it has been shown 
that MPP-1, when premixed with insoluble organic matrix material, can induce crystal 
formation in vitro
45
. Therefore, it is likely that MPP-1 and similar proteins serve a dual 




induce mineral formation (analogous to phosphophoryn’s role in dentiogenesis). 
Phosphoproteins UTMP-16 and P19 have also been identified in the CaCO3-based teeth 
of the sea urchins Lytechinus variegatus and Strongylocentrotus purpuratus, respectively, 
and have strong affinities for calcium ions
46-47
. Interestingly, these sea urchin 
phosphoproteins are so similar to PP that antibodies raised against PP also recognize 
these proteins
47
. Although the influence of phosphorylation on the calcium binding 
abilities of UTMP-16 and P19 has not been tested, it is likely (given the similarities to 
PP) that these phosphoproteins are important proteins in sea urchin tooth formation. 
 
1.2.2 Silica Biomineral proteins 
 Silicon, the second most abundant element on Earth, is the element of choice 
(instead of calcium) by organisms such as sponges, radiolarians, and diatoms that 
produce silicon dioxide (SiO2, also known as silica) in a process known as 
“silicification”
1,8,48-51
. Diatoms, the predominant producers of biosilica, are unicellular, 
photosynthetic algae that account for ~20 % of the Earth’s total photosynthetic carbon 
dioxide fixation
1,8,48
. There are more than 10,000 different species of diatoms in existence 
each displaying a unique porous, nanopatterned cell walls (termed frustules) made of 
silicon dioxide
48-51 
(Figure 1.2 A). The diatom cell wall consists of two overlapping parts, 
the epitheca and hypotheca, with each theca containing a valve and several girdle bands
48-
51


















Figure 1.2. Diatoms. A, SEM images of various species of diatoms
52-57
. Images taken 
from the web. B, Schematic representation of the diatom cell wall. 
 
 
 Silica deposition and morphogenesis occurs within a specialized membrane bound 
compartment termed the silica deposition vesicle (SDV)
48-51
. During cell division and 
interphase, separate SDVs develop during valve formation and girdle band formation. 
Subsequently, the complete mature silica structure is exocytosed to the cell surface
48-49,51
. 
Dissolution of isolated diatom silica cell walls using acidified ammonium fluoride 




embedded in the silica
58-63
. Given their intimate association with the diatom silica and 
their ability to form silica from silicic acid solutions in vitro, these proteins and LCPAs 
are believed to be components of the SDV and involved in diatom silica biogenesis.  
 
1.2.1.1 Silaffins and Silacidins  
 Silaffins (proteins with silica affinity) are a family of phosphoproteins that 
possess numerous additional posttranslational modifications
58-61
. Biochemical analysis of 
the proteolytically derived peptides natSil-1A1, natSil-1A2, and natSil-1B from 
Cylindrotheca fusiformis silaffin Sil1, revealed that all lysine side chains were alkylated 
and all serine and trimethylhydroxylysine residues are phosphorylated, making it 
zwitterionic in nature (Figure 1.3)
58-59
. The presence of phosphate moieties greatly 
influenced the ability of these silaffin-1 peptides to induce silica formation, in vitro
58-59
. 
In the presence of silicic acid, natSil1-A rapidly (within 10 min) precipitates silica in the 
form of nanospheres but this silica forming activity is completely lost after 























Figure 1.3. Chemical structure of native silaffin-1A1 peptide from the diatom C. 
fusiformis
59
. Image taken reference 59. 
    
 
 Other silaffins from C. fusiformis (natSil-2)
60
 and Thalassiosira pseudonana 
(tpSil1H, tpSil1L, tpSil2H, tpSil2L, and tpSil3)
61 
are not only phosphorylated and contain 
alkylated lysines and phosphorylation, they are also glycosylated and sulfated. 
Furthermore, amino acids such as dihydroxyproline (a rare amino acid) and 
phosphorylated hydroxyproline (a previously unknown amino acid) are present in 
tpSil1/2H and natSil-2, respectively
60-61
. T. pseudonana native silaffins and natSil-2 lack 
intrinsic silica forming capabilities in vitro, but in the presence of LCPA they are able to 
precipitate silica and control the amount and/or the structure of the silica produced 
(Figure 1.4 A)
60-61
. Thus, these silaffins are termed regulatory silaffins. Silaffins natSil-2, 
tpSil1/2H, and tpSil3 (in the presence of constant LCPA concentrations) produced silica 






At certain concentrations, however, these silaffins strongly inhibit silica formation 
(Figure 1.4 B)
60-61
. In contrast, lower molecular weight isoforms of tpSil1/2H (generated 
by intracellular proteolytic processing), silaffins tpSil1/2L, together with LCPA produce 















Figure 1.4 Silica precipitating activity of regulatory silaffins from C. fusiformis and 
T. pseudonana
60-61
. A, SEM images of the silica structure produced by natSil-2/natSil-1 
mixtures (black letters) and T. pseudonana silaffin-LCPA mixtures (text in red, green, or 
blue) in the presence of silicic acid. Scale bar for natSil-2 micrograph is 2 µm. All other 
scale bars are 1 µm. B, Influence of native silaffins on the silica precipitating activity 







 The ability of silaffins to inhibit silica formation may be depend on the degree of 
glycosylation. TpSil1/2L contains about 3-10 times fewer carbohydrates than silaffins 
tpSil1/2H and tpSil3 and did not inhibit silica formation
61
. At concentrations about one 
fourth the concentration required for tpSil3-mediated inhibition, tpSil1/2H was a potent 
inhibitor of silica formation
61
. Interestingly, tpSil1/2H contains nearly four times more 
carbohydrates than tpSil3 which perfectly correlates (linearly) with the concentration of 
silaffin required for inhibition
61
. The phosphate moieties on silaffins, on the other hand, 
appear to only stimulate silica precipitation as tpSil1/L and deglycosylated/desulfated 
natSil2 (in the presence of LCPAs), both of which consist mainly of phosphate groups, do 
not inhibit silica formation in vitro at any of the silaffin concentrations tested
60-61
.  
 More recently, phosphopeptides termed silacidins were isolated from T. 
pseudonana biosilica
62
. The silacidin peptides (Silacidin A, Silacidin B, Silacidin C) are 
products of proteolytic processing of a precursor protein rich in serine residues, all of 
which are phosphorylated, and in acidic amino acids making these peptides the first 
highly acidic peptides (pI < 3) to be isolated from diatom biosilica
62
 (Figure 1.5). There is 
no evidence of other posttranslational modifications in these peptides. In the presence of 
LCPA, micomolar amounts of silacidins induced the formation of silica nanospheres 
whose sizes increased with silacidin concentration and did not, at any concentration 











Figure 1.5. Chemical structure of a silacidin peptide from T. pseudonana. 
 
 
1.2.2.2 Long Chain Polyamines 
 Although long chain polyamines are not phosphoproteins, their intimate 
association with silaffins and silacidin warranted a discussion on LCPAs and their 
involvement in diatom biomineralization. All of the LCPAs identified from several 
species of diatoms have linear oligo-propyleneimine chains that vary in chain length and 
degree of methylation attached to putrescine, spermidine or propylenediamine
64
. Similar 
oligo-propyleneimine chains attached to lysine residues are found in silaffins (see Figure 
1.3).  The tight association of LCPAs with diatom silica and their influence of silica 
formation in vitro led to the hypothesis  that LCPAs are involved in silica formation in 
vivo. Consistent with this hypothesis is the observation by Hildebrand and co-workers 
that T. pseudonana cells treated with 1,3-diaminopropane dihydrochloride, an inhibitor of 
polyamine biosynthesis, exhibited a marked decrease in silica content of the cell walls 














Figure 1.6. Effect of polyamine synthesis inhibition on the biosilica structure of T. 
pseudonana
65




 In the presence of phosphate (a polyvalent anionic molecule), LCPAs-phosphate 
microdroplets form resulting in a phase separation from the aqueous solution
66
. The size 
of the microdroplet is dependent on the ratio of polyamine to phosphate ions and 
increases as the phosphate concentration increases. Since the microdroplets solidify to 
form silica spheres upon the addition of silicic acid, the size of the silica spheres formed 
by the polyamine-phosphate system is also dependent on phosphate concentration
66
. It 
has been hypothesized that in vivo, the highly phosphorylated silaffins and silacidin 
(instead of inorganic phosphate), are the polyanionic molecules that form electrostatic 
interactions with the polycationic LCPAs to induce a phase separated nanopatterned 
organic matrix (dependent on the silaffin) that may act as a template for silica 
formation
48,66
. The in vitro silica formation assays support this hypothesis since biosilica 




and the structure of the biosilica produce was dependent on the silaffin. 
 
1.3 Regulation of Phosphorylation by Protein Kinases and Phosphatases 
 
 The prevalence of phosphoproteins in biomineralizing organisms from many 
different taxa suggest that they are essential components of biomineral forming 
machinery. Furthermore, it has been demonstrated that phosphorylation of these proteins 
is critical for biomineralization activities. So how is the phosphorylation of these 
biomineralization proteins regulated? Regulation of phosphorylation of biomineral 
forming proteins is achieved by the action of various protein kinases and phosphatases
67
. 
In fact, the regulation, function, and intracellular localization of about 30 % of the 
proteins of a eukaryotic cell, depends on phosphorylation by protein kinases
68
. Protein 
kinases are enzymes that transfer phosphoryl groups from a donor molecule (usually 
ATP) in the presence of a divalent metal cation (usually Mg
2+
) to hydroxyl amino acids 





1.7). About 80 % of known protein kinases phosphorylate serine or threonine residues 
and are collectively known as serine/threonine (S/T) kinases
68
. The degree of 
phosphorylation of a protein can be regulated by phosphatases, which are enzymes that 
remove phosphate groups in a process known as dephosphorylation. Together, kinases 






Figure 1.7. Schematic representation of protein phosphorylation. 
 
 
 Tartrate resistant acid phosphatase (TRAP) is an iron-containing enzyme that is 
secreted by osteoclasts during bone resorption and has been shown to dephosphorylate 
the bone matrix proteins osteopontin and bone sialoprotein, in vitro
19,70
. Mice deficient in 
active TRAP resulted in mild osteopetrosis (excessive mineralization of bone)
71
 and 
reduced migration of osteoclasts on the bone surface
72
. In contrast, overexpression of 
TRAP leads to osteoporosis (demineralization of bone)
73
. Reduced phosphorylated forms 
of OPN and BSP bind less bone cells than their native, fully phosphorylated forms. It is 
therefore speculated that modulation of the phosphorylation level of bone matrix proteins 
by TRAP results in a gradient of variant hypo-phosphorylated forms of bone matrix 
proteins that facilitate the detachment and migration of bone cells along the bone surface 
and regulate biomineral formation
72
.  
 Although TRAP, a phosphatase, has been shown to be involved in bone 
biomineralization, not a single kinase has been identified to date that is responsible for 
phosphorylation of bone matrix proteins. This is quite surprising given that more than 10 
years ago in vitro phosphorylation of OPN, BSP and dentin protein phosphophoryn (PP) 






 and in a separate study, from kinases present with the 
extracellular matrix (termed ectokinases
77
) of bone cells
78
. These kinases (denoted as 
hydroxyapatite biomineralization kinases or HBKs hereafter) specifically phosphorylated 
serine or threonine residues in the vicinity of acidic amino acids
74-76,78
. Interestingly, the 
bone and teeth kinases mainly recognized the same consensus sequences, D/E- X 1 or 2- 
S/T or S/T-X-X-D/E (where X is usually any non-basic amino acid) that are recognized 
by cytosolic kinases casein kinase I and casein kinase II, respectively
68,74,78
. The HBKs 
phosphorylated the acidic protein casein and in some instances, could utilized GTP as the 
phosphate donor, a characteristic of cytosolic CKII
68,74-76,78
. Given the similarities of the 
HBKs to the cytosolic kinases CKI and CKII, the HBKs are commonly referred to as 
isoforms of CKI and CKII. However, several kinases (e.g. AMP-activated protein kinase 
and Polo-like kinase 1) phosphorylate casein
79-81
. In addition, a Golgi-localized HBK in 
mammalian cells recognized an additional consensus sequence, S-X-E/Sp (Sp is 
phosphoserine), resulting in phosphorylation of residues that were not phosphorylated by 
the casein kinases
75
. In the absence of any sequence information on the bone and teeth 
biomineralization kinases, there exists no definitive evidence that the bone and teeth 
biomineralization kinases are isoforms of the cytosolic casein kinases.  
 
1.4 Kinases in the Secretory Pathway 
 
 Identification and characterization of kinases involved in the phosphorylation of 
biomineral proteins would not only reveal another component of the biomineralizing 




secretory pathway, which is poorly understood
82-87
. The kinases that regulate 
phosphorylation of biomineralizing proteins must reside within the ER, Golgi, and/or the 
specialized biomineral forming compartments. This is due to the fact the biomineral 
forming proteins (the ones characterized to date) contain an N-terminal signal sequence 
for co-translational import into the endoplasmic reticulum (ER)
12,48,74,82
. During their 
transit from the ER to the mineral forming compartment, biomineralization proteins are 
posttranslationally modified and at no time are they exposed to the cytosol (Figure 1.8).  
 
 
Figure 1.8. Model for extracellular sorting of proteins. Biomineral forming proteins 
are co-translationally imported into the endoplasmic reticulum (ER) via an N-terminal 
signal peptide. These proteins are then transported through the Golgi apparatus before 
reaching the biomineral forming compartments. Alternatively, biomineral forming 
proteins could travel from the ER and directly to the mineral forming compartment 







 Nearly all of the kinases characterized to date function within the cytosol with the 
exception of two mammalian kinases, Four-joint and Fyn. Four-joint (Fj) is a 
serine/threonine kinase from Drosophila melanogaster that phosphorylates extracellular 
cadherin domains of Fat protein and related proteins within the Golgi apparatus
83
. Fat is a 
type II transmembrane protein that, like other cadherins, requires calcium for cellular 
adhesion. The authors speculate that phosphorylation of Fat by Fj influences the 
interaction of the cadherin domains in Fat and which in turn affect the adhesion activity 
of the Fat protein
83
. Thus, Fj represents the first molecularly characterized kinase that 
functions in the secretory pathway. A second endomembrane kinase, Fyn, is a tyrosine 
kinase that phosphorylates Grp94 in the ER lumen of mammalian cells
84
. 
Phosphorylation of Grp94 by Fyn is required for the Grp94 mediated export of molecules 
involved in immune responses to the cell surface
84
. Although Fj and Fyn are kinases 
operating within the secretory pathway, neither Fj nor Fyn catalyzes the phosphorylation 
of proteins involved in biomineralization.  
 
1.5 The Search for Diatom Biomineralization Kinases 
 
 As mentioned above, diatoms are suitable model organisms for studying 
biosilicification because:  i) abundant material can be obtained from cultures grown to 
high density
1,12,51
, ii) the complete genome sequence is available for some species
85,86
, 
and iii) methods have been established for genetic manipulation
87,88
. Furthermore, 
identifying all of the components necessary for diatom silicification could eventually lead 




carriers) that exhibit similar intricately nanopatterned structures as the diatom biosilica at 
ambient conditions
48,50,89
. The diatom Thalassiosira pseudonana was the first diatom to 




 Despite previous research on the kinases involved in bone and teeth formation, 
there is a complete lack of knowledge of kinases involved in the phosphorylation of 
biomineralization proteins from non-mammalian systems such as diatoms. Given the 
importance of the phosphate moieties in diatom biomineral forming proteins, the kinases 
that phosphorylate these proteins may be critical components in controlling the biosilica 
structure produced. For example, it is possible that various hypo-phosphorylated forms of 
silaffins and silacidin possess different biomineral forming activities which in turn affect 
the biosilica structure (e.g. porosity, mechanical strength, elasticity). 
 Also of interest is the cellular localization of these biomineralization kinases 
which may provide some valuable insight into the intracellular transport of silaffins. The 
current hypothesis is that silaffins are co-translationally imported into the ER (via an N-
terminal signal peptide) and then transported to the Golgi before reaching the silica 
deposition vesicle. This is supported by the presence of O-linked glycosylations which 
predominately occurs in the Golgi
60-61,90
. However, it cannot be excluded that silaffins are 
imported into the ER and then directly transported to the SDV by vesicles (see Figure 
1.8). In this scenario, additional silaffin modifying enzymes (such as those that add O-
linked glycosylations), may be present in the “silaffin transport” vesicles and not in the 
Golgi. Thus, if Golgi-resident kinases that phosphorylate silaffins and silacidin are 




would be substantiated.  
 Research dedicated to finding proteins involved in diatom biosilica formation has 
lead to the identification of several putative biomineralization kinases. Hildebrand and 
coworkers combined proteomics and transcriptomics to identify proteins potentially 
involved in diatom biomineralization
65
. After the addition of silicic acid to silicon-starved 
Thalassiosira pseudonana cells, proteins that were upregulated during silica formation 
(~4 to 6 hours after induction) were analyzed by mass spectroscopy and their 
corresponding genes were identified in the T. pseudonana genome database
65
. From this 
analysis, 31 proteins were found upregulated during biosilica formation, including two 
putative kinases, termed tpAK1 (gene id: newV2.0.grail.5.87.1) and tpSTK1 (gene id: 
newV2.0.grail.68.39.1). The mRNA expression of tpak1 and tpstk1 was also upregulated 
during silica biosynthesis and, in the case of tpstk1, the mRNA expression pattern was 
similar to that of silaffin tpsil3
65
. More recently, whole genome expression profiling of T. 
pseudonana under different nutrient limited conditions (i.e. silicon, iron, and nitrogen), at 
alkaline pH (pH = 9.4), and at low temperatures identified nearly 100 genes whose 
expression profile changed during silicon starvation
91
. Of these genes, the expression of 
tpsil3 was downregulated along with nearly 10 genes encoding for putative kinases 
during silica starvation, suggesting a possible relationship of these kinases to the silaffin 
tpSil3.  
 Are the putative kinases found in the Hildebrand and Mock studies involved in 
the phosphorylation of silaffins and/or silacidins? Where are these kinases located within 
the T. pseudonana cell? The answer to these questions requires extensive biochemical 




structural and functional characterization of tpAK1 and tpSTK1 (the putative kinases 
from the Hildebrand study), and tpSTK2 (a putative tpSTK1-like kinase) to assess their 
























CHAPTER 2: EXPERIMENTAL PROCEDURE 
 
2.1 Materials 
Isopropyl-D-thiogalactopyranoside, guanidinium hydrochloride, sucrose, ATP, 
NADH, phenylmethylsulfonyl fluoride, and trichloroacetic acid were purchased from 
EMD Biosciences. Dephosphorylated casein, histones I and II, myelin basic protein, 
fluorenylmethyloxycarbonyl chloride, phosphoserine, phosphotyrosine, 
phosphothreonine, antimycin A, chymotrypsin, cytochrome c, inositol diphosphate, 
sodium deoxycholate, tetramethoxysilane, and Igepal and were purchased from Sigma-
Aldrich. GTP and Tween-20 were purchased from Calbiochem. [γ-
32
P]-ATP was 
purchased from MP Biomedicals. Sic1 (SDESEESEDSVSSEDEDWW) was synthesized 
by Genescript. Peptide R5 (SSKKSGSYSGSKGSKRRIL) was provided by Dr. Nils 
Kröger. Purified native silaffin tpSil3 and hydrogen fluoride treated native Thalassiosira 
pseudonana silaffins were provided by Dr. Nicole Poulsen.  
 




Select regions of the silaffin genes natsil1 from Cylindrotheca fusiformis and 
tpsil1 and tpsil3 from T. pseudonana, each containing a hexahistidine tag, were cloned 
into the pET16 vector (Novagen). For expression of recombinant silaffins, a freshly 
transformed E. coli DH5α clone harboring pET16b/rSilX (where X = C, N, 1L, or 3) was 
inoculated into LB medium containing 100 µg/mL  ampicillin (LBamp), grown overnight 




of 0.6 (at λ= 600 nm). Expression of the recombinant silaffins was induced by the 
addition of IPTG to a final concentration of 1 mM. After growing for an additional 3 
hours at 37 ºC, the cells were harvested by centrifugation (4000g, 30 min, 4 ºC) and then 
washed once with 1 % (w/v) NaCl. Next, the cells were resuspended in E. coli lysis 
buffer (ECLB) containing 6 M Gdn-HCl (ECLB-G) and stirred for 15 minutes at 4 ºC. 
The cell mixture was sonicated (power setting 10, 30 sec on/off cycle) for 1 hour on ice 
and then centrifuged twice at 10,000g for 30 minutes at 4 ºC. Ni
2+
-NTA resin (Qiagen) 
equilibrated in ECLB-G was added to the cleared lysate (supernatant), mixed by gentle 
rotation overnight at 4 ºC and then loaded onto a column. The Ni-NTA agarose was 
washed with 10 column volumes (CV) of ECLB containing 20 mM imidazole and the 
his-tagged protein was eluted stepwise with 4 CV of elution buffer (50 mM Tris-HCl pH 
8.0, 1 M NaCl) containing increasing concentrations of imidazole (50 mM, 100 mM, 200 
mM, and 1 M). All fractions were analyzed by SDS-PAGE
93
, and fractions containing 
recombinant protein were pooled. Recombinant silaffin rSilC was subjected to an 
additional purification step using cation exchange chromatography. Briefly, Ni
2+
-NTA 
fractions containing rSilC were dialyzed once against 50 mM ammonium acetate. High S 
cation exchange resin (BioRAD) equilibrated in 50 mM ammonium acetate was added to 
the dialysate, mixed by rotation for 2 hours at 4 ºC, and then loaded onto a column. After 
washing the resin with 10 CV of 50 mM ammonium acetate and then 10 CV of 2 M 
NH3OH, rSilC was eluted with 5 CV of 2 M NaCl, 100 mM NH3OH, 50 mM ammonium 
acetate. The eluate was immediately neutralized with the dropwise addition of acetic acid. 




three changes (~10 hr between changes) and then lyophilized. The dried protein residues 
were dissolved in milliQ H2O. 
 
2.3 Mass Spectroscopic Analysis of recombinant silaffins 
 
The molecular mass of the recombinant silaffins were analyzed using a 
Micromass Quattro LC triple quadropole tandem mass analyzer. Samples were infused by 
a nanospray source in 50:50 water:acetonitrile containing 0.1 % formic acid. Mass 
spectroscopic analysis was performed at the Georgia Institute of Technology 
Bioanalytical Mass Spectrometry Facility.  
 
2.4 Quantification of Protein Concentration 
 
2.4.1 Bicinchoninic acid (BCA) Protein Assay
94
 
Aliquots of protein solutions (from 0.5 - 20 µL) were diluted with water to a final 
volume of 25 µL in a 96-well plate. BSA samples ranging from 0 to 20 μg protein were 
also prepared to generate a standard curve. A 1:50 dilution of 4 % CuSO4 in BCA reagent 
(Pierce) was prepared and 200 μL was added to each of the samples. The samples were 
incubated at 37 ºC for 30 minutes and then cooled at room temperature for 10 minutes. 







2.4.2 Amino Acid analysis
60
 
2.4.2.1 Phenylisothiocyanate (PITC) derivatization  
Amino acid standards were prepared as 100 mM stock solutions in H2O. 
Lyophilized recombinant silaffins were subjected to acid hydrolysis for 24 hours at 110 
ºC in 6 M HCl (Pierce) and then dried by lyophilization. The dried protein hydrolysates 
were dissolved in 50 µL ethanol/H2O/Triethylamine (in a 2:2:1 ratio) and then dried 
under vacuum. The dried hydrolysate was dissolved in 50 µL 
ethanol/H2O/Triethylamine/PITC (7:1:1:1) and then incubated at room temperature for 20 
minutes. The PITC treated hydrolysate was dried under a vacuum and then dissolved in 
50 µL 50 mM sodium phosphate buffer pH 6.4. Amino acid standards were derivatized 
with PITC as described above. After the final drying step, the PITC-derivatized amino 
acid standard was dissolved in 200 µL of 50 mM sodium phosphate buffer pH 6.4 to 
yield a final concentration of 0.5 nmol/µL. 
 
2.4.2.2 Reverse phase-high pressure liquid chromatography (RP-HPLC)  
The PITC-derivatized amino acid samples were separated using reverse phase 
HPLC on a Nucleosil C18 column (Machery-Nagel) by application of a linear acetonitrile 
gradient (buffer A: 50 mM sodium phosphate buffer pH 6.4, buffer B: 50 % acetonitrile, 
50 mM sodium phosphate buffer pH 6.4; gradient 0-70 % Buffer B in 40 min). PITC-
derivatized amino acids were detected at a wavelength of 254 nm. Relative amounts of 
PITC-derivatized amino acids from hydrolysates were determined by comparing the peak 









Recombinant silaffins were dissolved in 50 mM sodium phosphate citrate buffer 
(pH 4-10). A stock solution of monosilicic acid was prepared by hydrolyzing 1 M 
tetramethoxysilane (TMOS) in 1 mM HCl for 10 minutes at room temperature. 
Immediately after incubation, the monosilicic acid solution was added to the buffered 
silaffin solutions at a final concentration of 100 mM silicic acid, and then incubated at 
room temperature for 10 minutes. The precipitated silica was pelleted by centrifugation 
(16,000g for 5 min), washed three times with water, resuspended in 1 M NaOH, and then 
incubated at 95 ºC for 30 minutes. The concentration of silica in these solutions was 




2.6 Culture Conditions 
 
Thalassiosira pseudonana clone CCMP1335 was grown in an artificial seawater 
medium according to the North East Pacific Culture Collection
96
 at 18 ºC under constant 
illumination at 10,000-15,000 lux. 
 
2.7 Generation of a cDNA library coupled to oligo-dT25 magnetic beads 
 
T. pseudonana cells (5x10
7
 cells) were resuspended in 1 mL TRI-reagent (Sigma-
Aldrich) and then gently lysed for 30 seconds using 0.1 mL of glass beads (0.25-0.30 




manufacturer’s instructions. To remove contaminating DNA, the total RNA preparation 
was DNase treated in a final volume of 50 μL containing 1x One-Phor-All Plus buffer 
(GE Healthcare), 28.8 U RNA guard (GE Healthcare), and 1 U RNase-free DNase 
(Fermentas) for 30 minutes at 37 ºC. A second TRI-reagent RNA purification step was 
performed to remove the DNase and the total RNA concentration was measured 
spectrophotometrically at 260 nm and its quality was determined by agarose gel 
electrophoresis. Total RNA (5 µg) was coupled to oligo-dT25 magnetic Dynabeads
 
(Invitrogen) and equilibrated in 2x binding buffer (20 mM Tris-HCl pH 8.0, 1.0 M LiCl, 
2 mM EDTA all in diethylpyrocarbonate (DEPC) treated-H2O) by incubating the RNA-
bead mixture for 10 minutes at room temperature with constant shaking (1,400 rpm). The 
beads with attached T. pseudonana poly(A)+ RNA were washed with 10 mM Tris-HCl 
pH 8.0, 150 mM LiCl, 1 mM EDTA, and 0.05 % (v/v) Triton-X100 (Roche) three times 
and then incubated at 70 ºC in 1x First Strand Buffer (Invitrogen) for 10 minutes and then 
placed on ice. For cDNA synthesis, reverse transcription was performed in a final volume 
of 20 μL containing the oligo-dT25 beads with attached T. pseudonana poly(A)+ RNA, 
0.5 mM dNTPs, 5 mM dithiothreitol (DTT), 1x First Strand Buffer, 28.8 U RNA guard, 
and 200 U Superscript III (Invitrogen) at 55 ºC for 50 minutes. After heat inactivation of 
the enzyme at 70 ºC for 15 minutes, mRNA was removed by the addition of 5 U RNaseH 
(Fermentas) and incubated at 37 ºC for 20 minutes. The beads with attached cDNA were 
washed twice with TE buffer containing 0.05 % (v/v) Triton-X100 and then resuspended 
in 20 µL TE buffer. This resulted in a T. pseudonana cDNA library coupled to the oligo 









2.8.1 3’ RACE 
For amplification of the 3’-ends of the tpak1 and tpstk1 genes, two nested 3’ 
RACE PCRs were performed using gene specific sense primers AK 5 (5'-GAA AGT 
TGC TAC CGA AGA GG-3') or STK 5 (5'-TGC AGC AGG GCA GTG CAT CC-3') for 
the first PCR and AK 6 (5'-GCC ATT TTG AAG GAG CAT GC-3') or STK 6 (5'-GCA 
TCC AAG CAG TAC ATT CC-3') for the second PCR. The first RACE PCR (94 °C 20 
sec, 42 °C 20 sec, 72 °C 45 sec) was performed in a final volume of 50 μL containing 2 
μL Tp cDNA-beads, 1x PCR Buffer, 0.1 mM dNTPs, 0.50 μM ON670 (5’-CAG CCG 
CCG AAT TCC CAG (T)18-3’), 0.50 μM AK 5 or STK 5, and 0.25 µL Taq DNA 
polymerase (homemade). After 35 cycles of amplification, 1.0 µL of the reaction was 
used in a second PCR (35 cycles: 94 °C 20 sec, 55 °C 20 sec, 72 °C 30 sec) using sense 
primers AK 6 or STK 6 and antisense ON644 (5’-GCC GCC GAA TTC CCA GTT T-
3’). The 550-bp and 500-bp DNA fragments produced from tpak1 and tpstk1 gene 
amplification, respectively, were cloned into the pGEMT vector (Promega) and 
sequenced. 
 
2.8.2 5’ RACE 
The T. pseudonana cDNA-beads were prepared for 5’ RACE by adding a poly C-
tail to the 5’-end with terminal deoxynucleotidyltransferase (TdT) according to the 
manufacturer’s instructions (Fermentas). The cDNA sequences of the 5'-end of the tpak1 




CAT AGT TCA ACG CCC TAC TCC-3') or STK 9 (5'-GTA GTG ATA CTG TCT CCA 
TC-3') for the first PCR and AK 13 (5'-GAT GAT TGT GGT GGA GTT GC-3') or STK 
10 (5'-CCT CAC TGG TGA CGT AGT GA-3') for the second PCR. The first RACE 
PCR (94 °C 20 sec, 55 °C 20 sec, 72 °C 30 sec) was performed in a final volume of 50 
μL containing 2 μL Tp cDNA-beads, 1x PCR Buffer, 0.1 mM dNTPs, 0.50 μM GIA 
anchor primer (5’-GGC CAC GCG TCG ACT AGT ACG GGI IGG GII GGG IIG-3’), 
0.50 μM AK 14 or STK 9, and 0.25 µL Taq DNA polymerase. After 35 cycles of 
amplification, 1.0 µL of the reaction was used in a second PCR (35 cycles: 94 °C 20 sec, 
55 °C 20 sec, 72 °C 30 sec) using the sense primers AK 13 or STK 10 and the antisense 
anchor primer R2 (5’-GGC CAC GCG TCG ACT AGT AC-3’). The 500-bp DNA 
fragments produced from tpak1 and tpstk1 gene amplification were cloned into the 
pGEMT vector (Promega) and sequenced. 
 
2.9 Reverse Transcription (RT) PCR: tpAK1 and tpSTK1  
 
2.9.1 tpAK1 
The full length tpak1 cDNA was amplified by PCR (40 cycles: 94 ºC 20 sec, 58 
ºC 20 sec, 72 ºC 150 sec) using the sense primer (5'- ATG ACA GCT ACA CCG TAT 
AAC-3') and the antisense primer (5'-GTG AAG TAC AAT ACC CAA TGT CG-3') in a 
final volume of 50 μL containing 2.0 μL Tp cDNA-beads, 1x PCR Buffer, 0.1 mM 









The full length tpstk1 cDNA was amplified by PCR (40 cycles: 94 ºC 20 sec, 58 
ºC 20 sec, 72 ºC 90 sec) using the sense primer 5’-ATG AGA GTC ATA CGC AAT 
GTT TC-3' and the antisense primer 5'-CTA AAA GCT GAT AGG ACC GAT G -3' in a 
final volume of 50 μL containing 2.0 μL Tp cDNA-beads, 1x PCR Buffer, 0.1 mM 
dNTPs, 0.50 μM each primer, and 0.25 µL Taq DNA polymerase  (homemade).  
 
2.10 Cloning, Expression, and Isolation of recombinant tpAK1 
 
2.10.1 Cloning of recombinant tpAK1 
The coding region of tpak1 was amplified from Tp cDNA-beads by PCR (25 
cycles: 94 °C 20 sec, 58 °C 20 sec, 72 °C 150 sec) using the sense primer AK 5'-CAT 
ATG ACA GCT ACA CCG TAT AAC AGG-3' and the antisense primer 5'-GGA TCC 
CTA ATG GTG ATG GTG ATG GTG ACC TTC AAG TTG GGC CT-3', which 
introduced an NdeI restriction site (bold), a BamHI site (italic), and C-terminal 
hexahistidine tag (underlined), in a final volume of 50 µL containing 2.0 µL Tp cDNA-
beads, 1x PCR Extender buffer, 60 µM dNTPs, 0.50 μM each primer, and 2.5 U PCR 
Extender DNA polymerase mix (5 PRIME). The resulting 2.3-kb PCR was ligated into 
the pGEMT vector (Promega) and sequenced. Plasmid pGEMT/tpAK1 was digested with 
NdeI and BamHI and the resulting 2.3-kb DNA fragment was ligated into the 






2.10.2 Expression and Isolation of recombinant tpAK1 
Recombinant tpAK1, from an E. coli BL21 (DE3) clone harboring 
pET11a/tpAK1, was expressed as described for the recombinant silaffins (section 2.2). 
After the NaCl wash, the cells were resuspended in ECLB at 5 mL buffer/gram wet pellet 
weight. Lysozyme was added to a final concentration of 1 mg/mL and the mixture was 
incubated on ice for 30 minutes. The cells were lysed by sonication (power setting 10, 30 
sec on/off cycle for 1 hr) using a Misonix Sonicator 3000 and then centrifuged at 12,000g 
for 30 minutes at 4 ºC. The cell pellet was washed with 10 mL of ECLB containing 3 M 
urea and the mixture was sonicated as described above. After centrifugation of the lysate 
at 12,000g for 30 minutes at 4 ºC, the pellet was resuspended in ECLB containing 8 M 
urea (ECLB-U) and mixed by gentle rotation at 4 ºC for 30 minutes to solubilize 
inclusion bodies. The mixture was centrifuged at 12,000g for 30 minutes at 4 ºC. Ni
2+
-
NTA resin (Qiagen) equilibrated in ECLB-U was added to the solubilized inclusion 
bodies and mixed by rotation overnight at 4 ºC and then loaded onto a column. The resin 
was washed with 10 column volumes (CV) of ECLB containing 20 mM imidazole and 8 
M urea. Recombinant tpAK1 was eluted stepwise with 4 CV of ECLB-U containing 
increasing concentrations of imidazole (50 mM, 100 mM, 200 mM, and 1 M). All of the 
fractions were analyzed by SDS-PAGE
93
 and fractions containing recombinant tpAK1 
were combined. Recombinant tpAK1 was refolded by dialysis against tpAK1 refolding 
buffer (50 mM Tris-HCl pH 7.0, 0.1 M NaCl, 10 % (v/v) glycerol, and 1 mM PMSF) 
containing decreasing concentrations of DTT (1 mM, 0.5 mM, 0.2 mM, 0 mM), EDTA 




hours in each buffer. The dialysate was concentrated to ~4 mg/mL of recombinant tpAK1 
using a 10,000 MWCO centricon filter (Millipore). 
 




Sodium silicate (420 μM) was added to a 1.0-1.2 x 106 cells/mL T. pseudonana 
cell culture to achieve a high cell density (3.5-4.0 x 10
6
 cells/mL). The cells were pelleted 
by centrifugation (3,000g for 10 min), washed once in silicate free-artificial seawater 
medium (Si-ASW), and inoculated into Si-ASW medium in a polycarbonate bottle to a 
final density of 1.0 x 10
6
 cells/mL. The culture was stirred and aerated for 24 hours. Cell 
cycle progression was initiated by the addition of sodium silicate to a final concentration 
of 200 μM. At the indicated times equal culture volumes were harvested for total RNA 
isolation and cDNA synthesis (see section 2.7) and for Western Blot analysis (see section 
2.20). The tpstk1 gene was amplified using sense primer 5’-AAG CTT TCA GCT CAA 
CTT ATA CTT GCT CCC-3’ and antisense primer 5’-GAG CAG GCC TTC ACA TCA 
CAA CGC ACC GTC-3’. The tpsil3 gene was amplified using sense primer 5’-GGA 
CAC CAA GAG TGG AAA G-3’ and antisense primer 5’-TCA AGC GCT CAT GGA 
GTG G-3’. The tpsil1 gene was amplified using sense primer 5’-ATG AAA GTT ACC 
ACG TCA ATC-3’ and antisense primer 5’-AGA TCG CGA CGC AAC ATT C-3’. The 
tpsic gene was amplified using sense primer 5’-CGG ACT TTG TTG ATA GAT GAA 
CC-3’ and antisense primer 5’-ATG GTC AAG TAC AAC GTC CTC G-3’. The tpfcp9 
gene was amplified using sense primer 5’-TTC GAG GAT GAG CTC GGT G-3’ and 




25 cycles of amplification (94 °C 20 sec, 60 °C 20 sec, and 72 °C 40 sec) in a final 
volume of 50 μL containing Tp cDNA-beads (0.25 -1 µL), 1x PCR Buffer, 0.1 mM 
dNTPs, 0.50 μM each primer, and 0.25 µL Taq DNA polymerase (homemade). 
 
2.12 Genomic DNA isolation from T. pseudonana 
 
T. pseudonana wild type cells (2 x 10
8
 cells) were harvested by centrifugation 
(3,000g, 10 min, 18 ºC) and resuspended in 600 µL Nuclei lysis solution (Promega). 
Glass beads (100 µL) were added and the mixture was vortexed for 30 seconds. The 
mixture was heated at 65 ºC for 15 minutes and then cooled to room temperature before 
adding 1.5 µL of 10 mg/mL RNase A. Following a 15 minute incubation at 37 ºC, 250 
µL of Protein precipitation solution (Promega) was added to the mixture. The mixture 
was centrifuged at 16,000g for 30 minutes at 4 ºC and the supernatant was transferred to a 
fresh 1.5 mL eppendorf tube. Isopropanol (700 µL) was added to the supernatant and the 
mixture was incubated on ice for 20 minutes. The sample was centrifuged at 16,000g for 
1 minute at 4 ºC and the pellet was washed with 600 µL 70 % (v/v) ethanol. After 
centrifugation (16,000g, 1 min, 4 ºC), the pellet was air-dried for 15 minutes,  
resuspended in 50 µL of TE buffer and incubated at 65 ºC for 15 minutes. The T. 
pseudonana genomic DNA (Tp gDNA) concentration was estimated 












2.13.1 Cloning of recombinant tpSTK1 
As the tpstk1 gene was shown to contain no introns, the coding region of tpstk1 
was amplified from Tp gDNA by PCR (20 cycles: 94 °C 20 sec, 58 °C 20 sec, 72 °C 90 
sec) using the sense primer 5'-GCA GGC CTA TGA GAG TCA TAC GCA ATG TTT 
CTC-3' and the antisense primer 5'-CCA AGC TTC TAA TGG TGA TGG TGA TGG 
TGA AAG CTG ATA GGA CCG ATG CC-3', which introduced a StuI restriction site 
(bold), a HindIII site (italic), and C-terminal hexahistidine tag (underlined), in a final 
volume of 50 µL containing 400 ng Tp gDNA, 1x PCR Extender buffer, 60 µM dNTPs, 
0.50 μM each primer, and 2.5 U PCR Extender polymerase mix (5 PRIME). The 
resulting 1.5-kb PCR product was digested with StuI and HindIII, ligated into the 
StuI/HindIII sites of the pPROEX-HTb vector (Life Technologies) and introduced into E. 
coli DH5α. By this strategy a gene was generated that encodes the full length tpSTK1 
protein fused to an N-terminal hexahistidine tag and followed by a spacer region 
(DYDIPTT), an rTEV protease cleavage site, and a C-terminal hexahistidine tag. This 
fusion protein was termed recombinant tpSTK1. 
 
 2.13.2 Expression and Isolation of recombinant tpSTK1 
Recombinant tpSTK1, from an E. coli BL21 (DE3) clone harboring pPROEX-
HTb/tpSTK1, was expressed as described for the recombinant silaffins (section 2.2). 




8.0, 1 mM EDTA, 10 mM DTT, 25 % (w/v) sucrose). Lysozyme, DNase I, and MgCl2 
were added at final concentrations of 0.5 mg/mL, 19 µg/mL, and 2.0 mM, respectively. 
Subsequently, an equal volume of lysis buffer B (50 mM Tris-HCl pH 8.0, 0.1 M NaCl, 
10 mM DTT) was added and the cells were incubated at room temperature for 1 hour. 
EDTA was added to a final concentration of 6.7 µM and the cells were frozen in liquid 
nitrogen. The cell pellet was thawed for 30 minutes at 37 ºC. MgCl2 was added to a final 
concentration of 4.1 mM and the cells were incubated at room temperature for 1 hour. 
EDTA (6.7 µM) was added and the lysate was centrifuged at 23,000g for 30 minutes at 4 
ºC to pellet inclusion bodies. The pellet was resuspended in 10 mL of wash buffer I (50 
mM Tris-HCl pH 8.0, 1 mM EDTA, 10 mM DTT, 0.1 M NaCl) and then centrifuged at 
23,000g for 30 minutes at 4 ºC. The pellet was resuspended with 10 mL of wash buffer II 
(50 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.1 M NaCl, 1 mM DTT) and centrifuged at 
23,000g for 30 minutes at 4 ºC. The final pellet was dissolved in purification buffer (50 
mM Tris-HCl pH 8.0, 1 mM DTT, 0.5 M NaCl, 20 mM imidazole, 8 M urea) for 30 
minutes, and applied to a 1 mL HisTrap-FF column (GE Healthcare) (pre-equilibrated 
with purification buffer) at 4 ºC for 1 hour at 0.5 mL/min. The column was washed with 
25 mL of purification buffer before refolding of the protein was performed on the column 
with a linear gradient (0.5 mL/min, 50 min) from 100 % purification buffer to 100 % 
tpSTK1-refolding buffer (50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 20 mM imidazole) at 4 
ºC. After 25 mL washing with refolding buffer the protein was eluted with a linear 
gradient (0.5 mL /min, 20 min) from 100 % refolding buffer to 100 % elution buffer (50 
mM Tris-HCl pH 8.0, 0.5 M NaCl, 1 M imidazole). Fractions containing recombinant 
tpSTK1, as determined by SDS-PAGE
93




pH 8.0, 0.1 M NaCl, 10 % (v/v) glycerol, and 1 mM PMSF. The dialysate was 
concentrated to ~2 mg/mL recombinant tpSTK1 using a 3,000 molecular weight cut-off 
(MWCO) centricon filter (Millipore). 
 




Recombinant tpSTK1 (5 mg) was excised from a preparative SDS-PAG (Gel size: 
13 x 13 cm
2
, 2 mm thickness). The excised gel slice containing the recombinant protein 
was cut into several pieces. The pieces were crushed by passing them through a 1.0 mL 
syringe. Recombinant tpSTK1 was passively eluted from the crushed gel pieces by 
incubation in water overnight at 4 ºC with constant stirring. The mixture was then 
centrifuged at 100,000g for 30 minutes to pellet gel fragments. The protein solution 
(supernatant) containing  recombinant tpSTK1 was dried by lyophilization, the protein 
residue reconstituted in complete Freud’s adjuvant (source: Mycobacterium tuberculosis) 
and then injected into rabbits for polyclonal antibody production (Lampire Biological 
Laboratories). A tpSTK1 affinity matrix was generated by coupling 3.5 mg of SDS-PAG 
purified recombinant tpSTK1 to N-hydroxysuccinimide-activated HiTrap sepharose 
according to the manufacturer’s instructions (GE Healthcare). The rabbit antisera 
obtained 50 days after immunization was diluted 1:1 with PBS and applied to the tpSTK1 
affinity column via a peristaltic pump (setting 4, speed 1x) and re-circulated overnight at 
4 ºC.  The column was washed with PBS until the absorbance at 280 nm was less than 
0.05. The antibodies were eluted with 100 mM glycine pH 2.5 and fractions were 




neutralization). IgGs from affinity matrix purified anti-tpSTK1 and from the preimmune 
sera were obtained using a Protein G column (GE Healthcare) according to the 
manufacturer’s instructions. 
 
2.15 Western Blot analysis 
 
Samples were subjected to SDS-PAGE
93
 and then the gel was placed onto a 
nitrocellulose membrane presoaked in Tris-glycine transfer buffer pH 8.3 (25 mM Tris, 
192 mM glycine, 20 % (v/v) methanol, 0.025 % (w/v) SDS). Electrotransfer was 
performed using a wet transfer apparatus (BioRAD) at 100 volts for 1 hour. After 
transfer, the membrane was washed twice for 10 minutes in TBS containing 0.05 % (v/v) 
Tween-20 (TBST) and then incubated in TBS SuperBlock buffer (Pierce) for 30 minutes 
with rocking.  The membrane was washed three times for 10 minutes in TBST buffer and 
then incubated with 0.2 µg/mL anti-tpSTK1 (or 0.3 µg/mL anti-tpSTK2; see section 
2.21.2) polyclonal antibody in blocking buffer for 1 hour at room temperature. The 
membrane was washed twice with TBST and then incubated with anti-rabbit IgG 
horseradish peroxidase conjugate (1:10,000 dilution in TBST, Sigma-Aldrich) for 1 hour 
at room temperature with gentle rotation. After the incubation, the membrane was washed 
four times with TBST buffer and then incubated with SuperSignal Working Solution 
(Pierce) according to the manufacturer’s instructions. After incubation, the blot was 
placed in clear, colorless plastic wrap and exposed to X-ray film (Kodak). When using 




Tween-20 (PBST) was used instead of TBST and the blocking buffer was 2 % (w/v) 
bovine serum albumin (BSA) in PBST.  
 
2.16 Kinase Assays 
 
2.16.1 Radioactive assays 
Protein substrates (20 μg) were incubated with 10 µg of recombinant tpSTK1 or 
recombinant tpAK1 in kinase activity buffer (50 mM Tris-HCl pH 8.0, 10 mM MgCl2, 
and 10 µM ATP) with 2 μCi [γ-
32
P]-ATP for 1 hour at 37 ºC. To test for divalent metal 
ion requirement, MgCl2 was replaced by equal concentrations of CaCl2, MnCl2, or ZnCl2. 
Reactions were stopped by the addition of an equal volume of SDS sample buffer, 
incubated at 95 ºC for 15 minutes and run on a 15 % SDS-PAG. Following SDS-PAGE, 
the gel was fixed in 30 % (v/v) methanol, 7 % (v/v) acetic acid for 10 minutes at room 
temperature, washed with water, dried, and then exposed to an imaging plate (Fujifilm) 
overnight. The imaging plate was analyzed with a Fuji Fluorescence/Phosphor-imager.  
 
2.16.2 Luminescence based assays
97,99
 
Protein and peptide substrates (10 µg) were incubated with 10 µg of recombinant 
tpSTK1 (or tpSTK2-KD) in kinase activity buffer (50 mM Tris-HCl pH 8.0, 10 mM 
MgCl2, and 10 µM ATP) for 1 hour at 37 ºC. For recombinant tpSTK1, the test for 
divalent metal ion requirement was performed as described in section 2.16.1. For 




Promega) was added to the reaction and incubated at room temperature for 10 minutes. 
Luminescence was measured using a Synergy 2 Plate Reader (Biotek). 
 
2.17 Recombinant silacidin constructs 
 
2.17.1 Construction of pET28a/rSic 
A DNA molecule corresponding to nucleotides 154-730 of the silacidin  (tpsic) 
gene
62
 was amplified from Tp gDNA by PCR (20 cycles: 94 °C 20 sec, 58 °C 20 sec, 68 
°C 60 sec) using the sense primer 5’-CAT GCC ATG GGA ATC AAC AAA GTC CGC 
CGT CTC-3’ and the antisense primer 5’-GCC GCT CGA GCT AGT GAT GGT GAT 
GGT GAT GAT CAA ACA TCA TCA AAT CTT CAC T-3’, which introduced an NcoI 
site (bold), an XhoI site (italic), and a C-terminal hexahistidine tag (underline), in a final 
volume of 50 µL containing 500 ng Tp gDNA, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM 
each primer, 1.0 mM MgSO4, and 1.0 U Pfx DNA polymerase (Invitrogen). The resulting 
620-bp product, which encodes amino acids 52-184 of the silacidin precursor 
polypeptide, was digested with NcoI and XhoI, ligated into the NcoI and XhoI sites of 
pET28a and introduced into E. coli DH5α yielding expression plasmid pET28a/rSic. The 
DNA sequence of rSic in the pET vector was verified by sequencing. 
 
2.17.2 Construction of rSilNH10-rSic fusion
97
 
2.17.2.1 Cloning of rSilNH10 
rsilN was amplified from pET16b/rSilN by PCR (20 cycles: 94 °C 20 sec, 60 °C 




ATT GCT GAC-3' and the antisense primer 5'-CGC GGG ATC CGT GAT GGT GAT 
GGT GAT GGT GAT GGT GAT GCA AGA TAC GAA GTT CTT CCT C-3', which 
introduced an NcoI restriction site (bold), a BamHI site (italic), and C-terminal 
decahistidine tag (underlined), in a final volume of 50 µL containing 500 ng 
pET16b/rSilN, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM each primer, 1.0 mM MgSO4, and 
1.0 U Pfx DNA polymerase (Invitrogen). The 310-bp PCR product obtained was digested 
with NcoI and BamHI, ligated into the NcoI/BamHI sites of the pET28a vector (Novagen) 
and introduced into E. coli DH5α, yielding plasmid pET28a/rSilNH10. 
 
2.17.2.2 Cloning of rSilNH10-rSic 
The tpsic gene was amplified as described (section 2.10.1) except the sense 
primer 5’-CGC GGG ATC CAT GAT CAA CAA AGT CCG CCG TCT C-3’and the 
antisense primer 5’-GCC GCT CGA GCT ATG CAT CAA ACA TCA TCA AAT CTT 
CAC T-3’, which introduced a BamHI site (bold) and an XhoI site (italic), was used in the 
PCR reaction. The resulting 596-bp product was ligated into pJET1.2 (Fermentas) 
yielding plasmid pJET1.2/rSic. After confirming the rsic gene sequence by DNA 
sequencing, plasmid pJET1.2/rSic was digested with BamHI and XhoI, and the 596-bp 
product was ligated into the BamHI and XhoI sites of pET28a/rSilNH10 and then 
introduced into E. coli DH5α yielding expression plasmid pET28a/rSilNH10-rSic. The 
composition and correct orientation of the rSilNH10-rSic fusion gene was verified by 






2.17.3 Expression and isolation of recombinant silacidin constructs 
Recombinant silacidin constructs (rSic and rSilNH10-rSic) were expressed as 
described for the recombinant silaffins (section 2.2) except cells were grown in medium 
containing 100 µg/mL kanamycin instead of LB-amp. The silaffin-silacidin fusion 
protein (rSilNH10-rSic) was purified via Ni
2+
-NTA chromatography as described for the 
recombinant silaffins. 
 




Cyanogen Bromide (Acros Organics) dissolved in 70 % (v/v) formic acid was 
added to lyophilized rSilNH10-rSic at 1 mg CNBr per 0.1 mg dry protein. The reaction 
mixture was incubated at room temperature in the dark for 24 hours. Excess CNBr was 
removed by a steady stream of N2 gas, and the residue was dissolved in 0.2 mL H2O and 
lyophilized. The dry sample was resuspended in 1 M Tris, neutralized with 2 M NaOH, 
and incubated with Ni
2+
-NTA sepharose (GE Healthcare) in 50 mM Tris-HCl pH 8.0, 1 
M NaCl, 10 mM imidazole. The unbound material contained pure rSic, which was 
exhaustively dialyzed against 10 mM ammonium acetate. The dialysate was dried by 
lyophilization and the residue dissolved in H2O. 
 




Recombinant silaffins before and after incubation with recombinant tpSTK1 were 




application of a linear acetonitrile gradient (buffer A: 0.1 % (v/v) trifluoroacetic acid 
(TFA) in H2O, buffer B: 0.085 % (v/v) TFA in acetonitrile; gradient 0-25 % Buffer B in 
35 min). Proteins were detected at a wavelength of 226 nm. 
 
2.20 Chemical analysis of phosphorylated silaffins 
 
2.20.1 Phosphate release determination (malachite green method)
100
 
Lyophilized protein samples were resuspended in 25 µL of 10 % (w/v) 
MgNO3•6H2O (in 95 % (v/v) ethanol) and incubated at 95 ºC for 20 minutes and then 
ashed. After cooling to room temperature (RT), 200 µL of 1.2 M HCl was added to the 
sample, vortexed, and then incubated at RT for 20 minutes. Aliquots of the sample were 
added to 600 µL 1.2 M HCl and 200 µL of the phosphate reagent (3 parts 0.2 % (w/v) 
malachite green with 1 part 10 % (w/v) (NH4)6Mo7O24•4H2O), incubated at RT for 10 
minutes, and the absorbance at 660 nm was measured with a Shimadzu 
spectrophotometer. A standard curve was generated using 0 to 6 nmol KH2PO4. 
 
2.20.2 Phosphoamino acid analysis
101
 
2.20.2.1 Purification of phosphoamino acids 
Phosphoserine, phosphotyrosine, and phosphothreonine were prepared as 1 mM 
stock solutions in H2O. Lyophilized native tpSil3 and tpSTK1 phosphorylated rSil3 (100 
nmol based on phosphate content) were subjected to partial acid hydrolysis for 3 hours at 
110 ºC in 6 M HCl (Pierce) and then dried by lyophilization. The dried protein 




column containing 0.35 mL Dowex 50W-X8 (H+) cation exchange resin (BioRAD) 
equilibrated in 100 mM formic acid. The resin was then washed twice with 0.8 mL of 100 
mM formic acid. The flow-through and washes containing the phosphoamino acids were 
lyophilized.  
2.20.2.2 Fluorenylmethyloxycarbonyl (FMOC) derivatization 
The enriched phosphoamino acids were resuspended in 250 µL of 0.2 M H3BO3-
NaOH pH 6.2. The phosphoamino acids were derivatized by the addition of 250 µL of 15 
mM fluorenylmethyloxycarbonyl-HCl (FMOC-Cl), vortexed briefly, and the reaction was 
allowed to proceed for 60 seconds. To remove unreacted FMOC-Cl, the mixture was 
extracted with n-pentane. After allowing the phases to separate, the organic phase was 
removed by aspiration and the pentane extraction was repeated twice. In the last 
extraction step, the aqueous layer (bottom layer) was removed using a 1 mL syringe 
equipped with a pointed end 27.75 gauge needle. Phosphoamino acid standards (100 
nmol) were derivatized with FMOC as described above. 
 
2.20.2.3 Anion Exchange HPLC 
The FMOC-derivatized phosphoamino acid samples were subjected to high 
pressure anion exchange chromatography at a flow rate of 1.5 mL/min on a Partisil 10 
SAX WCS analytical column (Whatman). Separation of the FMOC-derivatized amino 
acids was performed with an isocratic elution in pH 3.9 buffer containing 55 % (v/v) 
methanol, 1 % (v/v) tetrahydrofuran, and 10 mM potassium phosphate at room 
temperature on the Agilent 1100 Series HPLC system. FMOC-derivatized phosphoamino 




2.21 Cloning, Expression, and Isolation of recombinant tpSTK2 Kinase Domain 
 
2.21.1 Cloning of recombinant tpSTK2-KD 
The coding region of the predicted kinase domain of tpstk2 (tpstk2-KD) was 
amplified from Tp cDNA-beads by PCR (20 cycles: 94 °C 20 sec, 60 °C 20 sec, 68 °C 60 
sec) using the sense primer 5'- CAT GCC ATG GAC CTG ACT GGT AAA ACT ATC-
3' and the antisense primer 5'-GGA ATT CCA TAT GTT AAT GGT GAT GGT GAT 
GGT GGA TGG ATG ATC CAA ATA AGA AG-3’ which introduced an NcoI 
restriction site (bold), an NdeI site (italic), and C-terminal hexahistidine tag (underlined), 
in a final volume of 50 µL containing 2 µL Tp cDNA-beads, 1x Pfx buffer, 60 µM 
dNTPs, 0.50 μM each primer, 1.0 mM MgSO4, and 1.0 U Pfx DNA polymerase 
(Invitrogen). The resulting 0.93-kb PCR product was digested with NcoI and NdeI,  
ligated into the NcoI/NdeI sites of the pET16b vector (Novagen) and introduced into E. 
coli DH5α yielding plasmid pET16b/tpSTK2-KD. The DNA sequence of tpstk2-KD in 
the pET vector was verified by sequencing.  
 
2.21.2 Expression and isolation of recombinant tpSTK2-KD 
Recombinant tpSTK2 kinase domain (from an E. coli BL21 (DE3) clone 
harboring pET16b/tpSTK2-KD) was expressed, purified from inclusion bodies, and 
refolded as described for recombinant tpSTK1 (section 2.13.2). Recombinant tpSTK2-
KD (6 mg) was purified from a preparative SDS-PAG and a tpSTK2 affinity column was 




rabbit antisera obtained 60 days after immunization (against recombinant tpSTK2-KD) 
(see section 2.14 for details).  
 





To generate a gene encoding cytosolically expressed GFP with a C-terminal ER 
retention signal (GFPDDEL), the egfp gene was amplified with the sense primer 5'-ACC 
AAA AAT GGT GAG CAA GGG CGA GGA C-3' and antisense primer 5’-GAT TCG 
CGG CCG CTT ACA GCT CGT CAT CCT TGT ACA GCT CGT CCA TGC C-3’, 
which introduced a NotI restriction site (bold) and the tetrapeptide DDEL (underlined) in 
a final volume of 50 µL containing 500 ng pTpfcp/ctGFP
87
, 1x Pfx buffer, 60 µM dNTPs, 
0.50 μM each primer, 1.0 mM MgSO4, and 1.0 U Pfx DNA polymerase  (Invitrogen). 
After 20 cycles of amplification (94 °C 20 sec, 60 °C 20 sec, 68 °C 45 sec) the resulting 
750-bp PCR product was digested with NotI and ligated into the EcoRV and NotI sites of 





To generate a fusion gene encoding the tpstk1 putative signal peptide (amino 
acids 1-24) fused to a C-terminal GFP tag, a region of the  tpstk1 gene (1-72) was 
amplified by PCR (20 cycles: 94 °C 20 sec, 60 °C 20 sec, 68 °C 20 sec) using the sense 
primer 5'-ACC AAA ATG AGA GTC ATA CGC AAT G-3' and the antisense primer 5’-




µL containing 200 ng Tp gDNA, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM each primer, 1.0 
mM MgSO4, and 1.0 U Pfx DNA polymerase (Invitrogen). The resulting 88-bp PCR 





24GFP. The orientation of the tpstk1 DNA fragment in the vector was verified by PCR (35 
cycles: 94 °C 20 sec, 55 °C 20 sec, 72 °C 30 sec) using a tpstk1 gene specific sense 
primer 5'- ACC AAA ATG AGA GTC ATA CGC AAT G -3') and the GFP 37 gene 
specific antisense primer in a final volume of 50 μL containing 500 ng pTpfcp/tpSTK11-
24GFP, 1x Dream Taq Buffer, 0.1 mM dNTPs, 0.50 μM each primer, and 1 U Dream Taq 
DNA polymerase (Fermentas). To introduce a C-terminal ER-retention signal on the 
pTpfcp/STK11-24GFP gene fusion, plasmid pTpfcp/tpSTK11-24GFP was then used as a 
template for PCR amplification of a tpSTK11-24GFPDDEL encoding gene using the sense 
primer 5'-ACC AAA ATG AGA GTC ATA CGC AAT G-3' and the antisense primer 5'-
GAT TCG CGG CCG CTT ACA GCT CGT CAT C-3', which introduced a NotI 
restriction site (bold) and the diatom ER retention tetrapeptide DDEL (underlined) in a 
final volume of 50 µL containing 500 ng plasmid, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM 
each primer, 1.0 mM MgSO4, and 1.0 U Pfx DNA polymerase (Invitrogen). The resulting 
810-bp product was digested with NotI and ligated into the EcoRV and NotI site of the 
previously described vector pTpfcp generating pTpfcp/tpSTK11-24GFPDDEL.  
 
2.22.3 tpSTK1-GFP  
The tpstk1 gene was amplified from T. pseudonana genomic DNA by PCR using 
the sense primer 5'-ACC AAA ATG AGA GTC ATA CGC AAT G-3', which introduced 




primer 5'-AAA GCT GAT AGG ACC GAT GCC-3' in a final volume of 50 µL 
containing 200 ng Tp gDNA, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM each primer, 1.0 
mM MgSO4, and 1.0 U Pfx DNA polymerase (Invitrogen). The 1.5-kb product obtained 
after 20 cycles of PCR amplification (94 °C 20 sec, 60 °C 20 sec, 68 °C 90 sec) was 
blunt-end ligated into the EcoRV site of plasmid pTpfcp/ctGFP
87
 to generate plasmid 
pTpfcp/tpSTK1GFP. The orientation of tpstk1 in the vector was confirmed by restriction 
mapping and the sequence confirmed by DNA sequencing. 
 
2.22.4 BiPGFPDDEL  
The tpbip gene was amplified from Tp gDNA by PCR using the sense primer 5’- 
ATC ATA ATC ATG GCG TTC AAA CGG CGG TTC-3’and the antisense primer 5’- 
GGT GGC GGA GAC GAT AAT GTC GGA TTT-3’ was in a final volume of 50 µL 
containing 200 ng Tp gDNA, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM each primer, 1.0 
mM MgSO4, and 1.0 U Pfx DNA polymerase (Invitrogen). The 2.03-kb product obtained 
after 20 cycles of PCR (20 cycles: 94 °C 20 sec, 60 °C 20 sec, 72 °C 130 sec) 
amplification was blunt-end ligated into the EcoRV site of plasmid pTpfcp/ctGFPDDEL to 
generate plasmid pTpfcp/tpBiPDDEL. The orientation of tpbip in the vector was verified by 
restriction mapping and the sequence confirmed by DNA sequencing. 
 
2.22.5 GFP-tpSTK1  
The tpstk1 gene was amplified from Tp gDNA as described in section 2.22.3, 
except the antisense primer 5’- CCA AGC TTC TAA AAG CTG ATA GGA CCG ATG 




amplification was blunt-end ligated into the EcoRV site of plasmid pTpfcp, in which the 
KpnI site had been destroyed, to generate plasmid pTpfcp(-KpnI)/tpSTK1. The tpstk1 
sequence was confirmed by DNA sequencing. A second PCR (20 cycles: 94 °C 20 sec, 
59 °C 20 sec, 68 °C 45 sec) was performed on an eGFP-containing plasmid with the 
sense primer GFP 40 (5’-GCG GTA CCA TGG TGA GCA AGG GCG AGG A-3’) and 
the antisense primer GFP 41 (5’-GCG GTA CCC TTG TAC AGC TCG TCC ATG CC-
3’), which introduced KpnI restriction sites (bold), in a final volume of 50 µL containing 
500 ng plasmid tpfcp/ctGFP
87
, 1x Pfx buffer, 60 µM dNTPs, 0.50 μM each primer, 1.0 
mM MgSO4, and 1.0 U Pfx DNA polymerase (Invitrogen). The 720-bp DNA fragment 
was cloned into pJET1 (Fermentas) to generate pJET1/GFP. Positive clones were 
identified and sequenced using pJET1 and pJET2 primers. Plasmid pJET1/GFP was 
digested with KpnI and the 720-bp insert was cloned into pTpfcp (-KpnI)/tpSTK1 via a 
KpnI site in the tpstk1 gene to generate pTpfcp (-KpnI)/ GFP-tpSTK1. The orientation of 
the GFP in the vector was verified by PCR (35 cycles: 94 °C 20 sec, 58 °C 20 sec, 72 °C 
45 sec) using a tpstk1 gene specific sense primer 5'-GCA TCC AAG CAG TAC ATT 
CC-3' and the GFP 37 gene specific antisense primer 5’- CCG TAG GTG GCA TCG 
CCC TCG C -3’ in a final volume of 50 μL containing 500 ng pTpfcp (-KpnI)/ GFP- 
tpSTK1, 1x PCR Buffer, 0.1 mM dNTPs, 0.50 μM each primer, and 0.25 µL Taq DNA 
polymerase (homemade).  
The sequences of all PCR products were verified by DNA sequencing. Plasmids 
(5 µg) were introduced into T. pseudonana cells by microparticle bombardment using an 
established method
87
. T. pseudonana cells expressing BiP1-27GFP and BiP1-39GFPDDEL 




2.23 Fluorescence Microscopy 
 
Epifluorescence microscopy imaging was performed on an inverted microscope 
(Axiovert 200, Zeiss) equipped with a GFP longpass filter set (Ex: 450-490 nm, beam 
splitter FT 510 nm, Em: LP515; Zeiss). Confocal fluorescence microscopy was 
performed by Dr. Nicole Poulsen.  
 




2.24.1 Differential Centrifugation 
One liter of T. pseudonana cells (1.0-1.5 x 10
6
 cells/mL) was harvested by 
centrifugation (3000g, 10 min, 18 ºC), washed once with ice cold Membrane buffer (MB) 
containing 250 mM sucrose and 1x protease inhibitor cocktail (Roche) (MB-SPI), and 
then resuspended in 3 mL of MB-SPI. The cells were equally distributed into three 2 mL 
tubes, 0.5 mL of glass beads were added to each tube, and the tubes were vortexed for 30 
seconds. The glass beads were allowed to settle, the supernatants removed from each 
tube, combined, and then centrifuged at 16,000g for 2 minutes at 4 ºC (supernatant = 
fraction S0). The pellets were resuspended in 1.0 mL of MB-SPI and treated with glass 
beads as described above. After three lysis/centrifugation cycles, the S0 fraction was 
centrifuged at 16,000g for 15 minutes at 4 °C. The pellet (P1) was resuspended in MB-
SPI and the supernatant (S1) was centrifuged at 100,000g for 1 hour at 4 °C yielding 





2.24.2 Sucrose Density Gradient Centrifugation 
For fractionation of membranes by sucrose density gradient centrifugation the P2 
fraction was brought to 20 % (w/v) sucrose in MB containing 1x protease inhibitor 
cocktail (Roche) (MB-PI) and layered atop a stepwise sucrose gradient (sucrose 
concentrations in % (w/v): 22.5, 25.0, 27.5, 30.0, 32.5, 35.0 in MB-PI). After 
centrifugation at 100,000g for 24 hours at 4 °C, each sucrose layer was collected (top 
layer = F1, bottom layer = F7), diluted 5-fold with MB containing 1 mM PMSF, and then 
centrifuged at 100,000g for 1 hour at 4 °C. Each membrane pellet was resuspended in 1.0 
mL of MB or MB-SPI depending on application. To solubilize membranes, fractions 
were incubated with 1 % (v/v) Igepal in MB for 1 hour at 4 ºC, with rotation, and then 
centrifuged at 100,000g for 1 hour at 4 ºC. 
 




Subcellular fractions in membrane buffer (MB) were extracted with acetone (80 
% (v/v) final concentration) for 5 minutes on ice and then centrifuged (16,000g, 10 min, 4 
°C).  The absorbance at 652 nm of the supernatant was measured and the concentration of 




The solid residue remaining after acetone extraction was washed three times with 100 % 




at 95 °C for 5 minutes. Protein concentrations were determined by BCA assays (see 
section 2.4.1).  
2.26 Precipitation of Secreted Proteins 
 
T. pseudonana cells (density 1.0 - 1.5 x 10
6
 cells/mL) were pelleted by 
centrifugation at 3,000g for 10 minutes at 18 ºC and the supernatant was filtered through 
a 0.2 µm filter (Corning). Proteins in the supernatant were precipitated by the addition of 
TCA (final concentration 8.5 % (w/v)) and sodium deoxycholate (final concentration 0.9 
% (w/v)). After incubation for 15 minutes at room temperature, the sample was 
centrifuged at 16,000g for 10 minutes at 4 °C. The precipitate was washed with acetone, 




2.27 Marker Enzyme Assays  
 
The cytosolic fraction or membrane fractions from sucrose gradients (intact and 
detergent-solubilized) containing 10 µg total protein (as determined by BCA analysis) 
were used in each assay. 
 
2.27.1 Triton-Stimulated Inositol diphosphatase (IDPase) Assay
103
 
To test for the presence of Golgi membranes, subcellular fractions were incubated 
in assay buffer containing 30 mM Tris-MES pH 7.5, 3 mM MgSO4, 50 mM KCl, 3 mM 
IDP, and with or without 0.025 % (v/v) Triton-X100 for 1 hour at room temperature. 




for 10 minutes at 4 °C, the amount of inorganic phosphate in the supernatant was 
determined using the malachite green method (see section 2.20.1). The activity of IDPase 
(nmol Pi released/min) was obtained by the difference of activity of samples with Triton 
and those without Triton. 
 
2.27.2 Vanadate sensitive adenosine triphosphatase (vsATPase) Assay
104
 
To test for the presence of plasma membranes, the subcellular fractions were 
incubated in assay buffer containing 30 mM Tris-MES pH 6.5, 3 mM MgSO4, 50 mM 
KCl, 8 mM ATP, 100 mM KNO3, 5 mM NaN3, and with or without 0.025 % (v/v) Triton-
X100 for 1 hour at room temperature. To identify ATPases sensitive to vanadate, 50 μM 
Na3VO4 was added to the assay buffers. Proteins were precipitated as described in section 
2.26 and the amount of inorganic phosphate in the supernatant was determined using the 
malachite green method (see section 2.20.1). The activity of vsATPase (nmol Pi 
released/min) is the loss of activity in the presence of vanadate from the total ATPase 
activity (i.e. without vanadate added). 
 
2.27.3 Antimycin insensitive NADH-cytochrome c reductase (CCRase) Assay
103
 
To test for the presence of ER membranes, subcellular fractions were added to 
assay buffer containing 50 mM sodium phosphate pH 7.5, 30 µM cytochrome c, and with 
or without 1 µM antimycin A. The reaction was initiated by the addition of 0.1 mM 




 for cyt 
c). The activity of CCRase (nmol Cyt c reduced/min) is obtained by the difference of 





2.27.4 Cytochrome c oxidase (COx) Assay
103
 
To test for the presence of mitochondria subcellular fractions were added to assay 
buffer containing 50 mM sodium phosphate pH 7.5, 5 mM MgCl2, and 10 mM KCl, and 
with or without 0.02 % (v/v) Triton-X 100. Cytochrome c was reduced by molar excess 
of sodium dithionite and then aerated with nitrous gas for 5 minutes to remove excess 
sodium dithionite. The reaction was initiated by the addition of 80 µM cyt c (reduced) 










Intact and detergent solubilized (1 % (v/v) Igepal)  membranes from fractions F4 
and F5 (10 µg of total protein) in MB containing 250 mM sucrose were incubated in the 
absence or presence of chymotrypsin (0.3 µg/µL or 1.0 µg/µL) for 1 hour on ice. To 
inhibit the protease, PMSF was added at a final concentration of 5 mM. For SDS-PAGE 
and Western blot analysis (see section 2.15), an equal volume of 2x SDS loading buffer 
was added to the membrane fractions and incubated at 95 °C for 15 minutes. In addition 
to Western blot analysis, the membranes were assayed for CCRase activity or IDPase 












T. pseudonana cellular membrane fractions F4 and F5 (intact and detergent-
solubilized) were incubated at 4 °C for 2 hours with the indicated concentrations of IgG 
or in the absence of IgG. Subsequently, luminescence-based kinase assays using 





















CHAPTER 3: RESULTS 
 
3.1 Recombinant silaffins 
 
3.1.1 Purification of recombinant silaffins
92
 
To be tested as substrates in kinase assays, four recombinant silaffin domains 
(termed rSil3, rSil1L, rSilN, and rSilC) encoded by select regions of Thalassiosira 
pseudonana (tpsil3, tpsil1l) or Cylindrotheca fusiformis (sil1) silaffin genes were 
expressed in E. coli, with each recombinant silaffin possessing a C-terminal hexahistidine 
tag (Appendix A). Characteristics of these proteins are shown in Table 3.1. One feature to 
note is the abundance (21 % to 43 % of the total protein) of hydroxyl amino acids, 
especially serine and threonine, in the recombinant silaffins that are potentially 
phosphorylated by tpAK1 or tpSTK1.  
 
Table 3.1. Properties of recombinant silaffins. The theoretical molecular mass (Mtheor) 
in kilodaltons (kDa) and theoretical isoelectric point (pI) of each recombinant silaffin are 
based on the amino acid sequence of the protein without any modifications. S+T = 
content of serine and threonine, respectively. T = content of tyrosine. 
 
 rSilC rSil1L rSil3 rSilN 
Mtheor (kDa) 17.6 11.8 22.1 9.9 
pI theor 11.8 10.6 9.4 3.8 
S + T 36 % 23 % 21 % 30 % 






The presence of a C-terminal hexahistidine tag allowed for purification of the 
recombinant silaffins to homogeneity via Ni
2+
-NTA chromatography. SDS-PAGE 
analysis demonstrated the purity of the recombinant silaffins (Figure 3.1). However, the 
recombinant silaffins exhibited lower mobilities (up to ~50 % lower) through an SDS-
PAG than predicted by their theoretical molecular masses. The discrepancy in mobilities 










Figure 3.1. Recombinant silaffins rSilC, rSil1L, rSil3, and rSilN. Coomassie-stained 
SDS-PAG of recombinant silaffins purified via Ni
2+
-NTA chromatography. The band in 
the rSil1L lane labeled with an asterisk represents the monomer, whereas the band of 




Delayed migration of proteins in an SDS-PAG is also observed when the proteins 
carry posttranslational modifications. In theory, this should not be the case for the 
recombinant silaffins as E. coli does not incorporate posttranslational modifications. 
Indeed, mass spectroscopic analysis of the recombinant silaffins confirmed that these 




3.1.2 Quantification of recombinant silaffins 
Colorimetric methods, like the bicinchoninic acid (BCA) assay
94
, are commonly 
used to determine protein concentration because these methods are fast (results within 
minutes) and inexpensive. However, BCA color formation is strongly influenced by the 
presence of cysteine, tyrosine, and tryptophan residues, often leading to an 
overestimation of the protein concentration
105
. Although more tedious, amino acid 
analysis (AAA) is less sensitive to the amino acid composition of a protein and, therefore 
more accurately determines the protein concentration
106
. To determine the amount of 
recombinant silaffins purified from E. coli, both amino acid analysis and BCA assays 
were performed. The concentrations of each protein determined by AAA and BCA 




Table 3.2.  Protein concentrations of recombinant silaffins determined by Amino 
Acid analysis (AAA) and BCA analysis (BCA).  
 
 rSilC rSil1L rSil3 rSilN 
BCA (mg/mL) 10.0 3.3 15.8 10.0 




The BCA protein concentrations for all of the recombinant silaffins were 
significantly higher (at least 2-fold) than the concentrations obtained by amino acid 
analysis. For three of the recombinant silaffins (rSilC, rSil1L, and rSil3) the 




and tyrosine residues as these amino acids can form colored, copper-BCA complexes 
independent of the protein. Recombinant silaffin rSilN however, does not contain any of 
these residues and its concentration was the most overestimated (3.5-fold) of all of the 
proteins tested.  
 
3.1.3 Mineral forming capabilities of recombinant silaffins
92
 
To determine if the recombinant silaffins retained their silica precipitating ability, 
each recombinant silaffin was incubated for 10 minutes in silicic acid solutions covering 
the pH range of 4-10. At pH values in the range of 6-10, recombinant silaffins rSil3, 
rSil1L, and rSilC exhibited precipitation activity in a dose-dependent manner (i.e. the 
amounts of silica produced increased linearly with the amounts of silaffin added to the 
silicic acid solutions (Figure 3.2)). As rSilN (the only negatively charged silaffin) and the 
control without silaffins did not induce silica precipitation, the formation of these silica 
precipitates is presumably due the interaction of the polycationic silaffins (rSil3, rSil1L, 
and rSilC) with the negatively charged colloidal polysilicic acid particles that form 
rapidly at pH ≥ 6.0. Although the recombinant silaffins lack posttranslational 
modifications, these proteins are capable of forming biominerals in vitro and are 
therefore good substrates to test the phosphorylation activities of putative kinases tpAK1 






















Figure 3.2. Silica formation by recombinant silaffins. Correlation between the 
amounts of recombinant silaffin added to a buffered silicic acid solution (50 mM sodium 
phosphate/citrate pH 7) and the amount of silica precipitated. Each data point represents 
the average of three independent measurements (standard deviation ≤ 10 %). The 





3.2 Putative kinase tpAK1 
 
3.2.1 TpAK1 DNA sequence analysis  
TpAK1 was one of two putative kinases identified in a combined proteomics and 
genomics study by Hildebrand and coworkers
65
 (see section 1.5). Reverse transcription 
PCR (RT-PCR) and RACE PCR showed that the tpak1 gene (see Appendix C) contains 
only four introns instead of the five predicted by the tpak1 gene model in the 
Thalassiosira pseudonana genome database
85
. The tpak1 gene encodes a 741 amino acid 






 algorithm revealed that the N-terminal domain exhibits homology (e-
value: e-29) to the catalytic domain of alpha kinases, a unique family of eukaryotic 
kinases that share no sequence homology with other kinase families (Figure 3.3 B). 
Although alpha kinases have no detectable sequence identity with the other kinase 
families, the alpha kinase domain is structurally similar to serine/threonine kinases and 
contains many of the conserved residues required for protein phosphorylation
108
. TpAK1 
is predicted, by sequence analysis programs
108
, to contain a Tudor domain whose general 
function is currently unknown. No N-terminal signal peptide for targeting to the 
endoplasmic reticulum (ER) (based on analysis using Signal P program
109
) or 









Figure 3.3. Putative kinase tpAK1. A, Schematic representation of predicted tpAK1 
domain structure. The blue oval represents the predicted alpha kinase domain and the 
orange box indicates the tudor domain. Numbers indicate the amino acid positions at the 





3.2.2 Recombinant tpAK1 Substrate Specificity 
To investigate whether tpAK1 is a protein kinase, the full length protein was 
expressed as a fusion with a C-terminal hexahistidine tag (see Appendix D) and purified 
from E. coli (Figure 3.4). TpAK1 was insoluble in E. coli (inclusion bodies) and therefore 
had to be purified under denaturing conditions (8 M urea). The purified protein was 
subjected to conditions that promote protein refolding (see section 2.10.2 for 










Figure 3.4. Expression and Isolation of recombinant tpAK1. Coomassie-stained SDS-
PAG. Identical amounts of cells from an E. coli clone harboring a pET11a plasmid 
encoding recombinant tpAK1 were loaded before (-) and after 3 hours of induction with 
IPTG (+). After solubilization of the inclusion bodies with urea and adsorption of the 
solubilized material to Ni-NTA agarose, pure recombinant tpAK1 (rAK1) was refolded 
by dialysis.  
  
 
To determine whether tpAK1 is a protein kinase, its ability to phosphorylate 
purified recombinant silaffins and commercial kinase substrates (dephosphorylated 




gamma phosphate radiolabeled ATP ([γ-
32
P]-ATP) as the phosphate donor, the 
incorporation of radiolabeled phosphates to the protein substrates by tpAK1 was analyzed 
by SDS-PAGE. Recombinant tpAK1 showed no phosphorylation activity with any of the 
substrates tested (Appendix E). The lack of kinase activity may be due to:  
i) Recombinant tpAK1 was not folded into an active conformation under the 
applied refolding conditions. 
ii) Recombinant tpAK1 has substrate specificity for substrates different from 
those that were tested. 
iii) Recombinant tpAK1 may require an unknown cofactor for its activity. 
Due to the lack of phosphorylation activity, further characterization of tpAK1 was 
discontinued. 
 
3.3 Putative kinase tpSTK1 
 
3.3.1 TpSTK1 DNA sequence analysis 
The full length tpstk1 gene, the other putative kinase from the Hildebrand study
65
, 
was determined by RACE-PCR and RT-PCR. RT PCR confirmed the tpstk1 gene model 
in the Thalassiosira pseudonana genome database (see Appendix F). Analysis of the 55 
kDa protein (Figure 3.5 B) encoded by the tpstk1 gene using primary sequence analysis 
programs
107-108
 revealed a predicted a coiled-coil domain and an ATP binding kinase 
domain with homology (e value: e-16) to the catalytic domain of serine/threonine kinases 
(Figure 3.5 A). The first 24 amino acids are predicted to be an N-terminal signal 




structural characteristics of both sequence elements are very similar, making them 






Figure 3.5. Putative kinase tpSTK1. A, Schematic representation of the predicted 
tpSTK1 domain structure. SP or TM = putative signal peptide or transmembrane domain, 
respectively. The gray zig-zig indicates the predicted coiled-coil, and the red oval shows 
the putative serine threonine (S/T) kinase domain. Numbers indicate the amino acid 




3.3.2 Cell cycle specific expression of tpSTK1 
As observed by Hildebrand and co-workers
65
, the expression of tpstk1 mRNA is 
strongly up-regulated during silica formation in synchronized T. pseudonana cells, which 
closely follows the expression pattern of the silaffin-encoding gene, tpsil3, and is similar 
to that of tpsil1, another silaffin encoding gene (Figure 3.6). The increased tpsil1 mRNA 
expression one hour into the cell cycle progression coincides with the production of a few 
girdle bands at this time. Given that silacidins are also embedded in the diatom biosilica 
and are able to precipitate silica in vitro
62
, the mRNA expression of the silacidin 
encoding gene tpsic from 0 hours to 10 hours in synchronized T. pseudonana cells was 
monitored. As observed with the silaffins, the mRNA expression of the silacidin-
encoding gene, tpsic is upregulated during valve formation (Figure 3.6). However, the 
























Figure 3.6. Cell cycle-specific mRNA expression of native tpSTK1. Time course of 
tpstk1 mRNA expression in synchronized T. pseudonana cells. The times refer to hours 
after addition of silicic acid to silicon-starved cells. For each time point, cells from equal 
culture volumes were used for cDNA synthesis. Reverse transcription was performed 
from identical amounts of cDNA using primers specific for the indicated genes: tpsil3 
and tpsil1, genes encoding silaffins tpSil3 and tpSil1, respectively; tpsic, gene encoding 
silacidin tpSic; tpfcp, gene encoding a fucoxanthin chlorophyll-associated protein 
(tpFCP) that is constitutively expressed in T. pseudonana under constant illumination (A. 
Scheffel and N. Kröger, unpublished communication).  
 
 
To investigate expression of the tpSTK1 protein during the T. pseudonana cell 
cycle, a polyclonal antiserum was produced against a recombinant version of the protein 
(see section 2.14). From the antiserum, anti-tpSTK1 IgG antibodies were obtained by 
dual affinity chromatography on a recombinant tpSTK1-loaded column followed by 
protein G-agarose. The anti-tpSTK1 IgGs specifically detected a protein with an apparent 
molecular mass of about 60 kDa in a T. pseudonana whole cell lysate (Figure 3.7 A), 
which closely matches the predicted molecular mass of tpSTK1 (55 kDa). Western blot 
analysis of whole cell lysates from a synchronized T. pseudonana culture detected an 




maximum between 4 and 6 hr), demonstrating that biosynthesis of the tpSTK1 protein 
closely followed expression of the mRNA (Figure 3.7 B). The high level of the tpSTK1 
protein was maintained at 8 and 10 hours, whereas the tpstk1 mRNA level decreased over 






Figure 3.7. Cell cycle-specific protein expression of native tpSTK1
97
. A, Western blots 
probed with anti-tpSTK1 IgG (0.2 µg/mL) and preimmune IgG (0.2 µg/mL) that were 
isolated from the same rabbit. Lanes “rSTK1” contained 100 ng of purified recombinant 
tpSTK1; lanes labeled “cells” contained lysates from 1.3×10
6
 T. pseudonana cells. B, 
Time course of tpSTK1 protein expression in synchronized T. pseudonana cells. The 
times refer to hours after addition of silicic acid to silicon-starved cells. For each time 
point, cells from equal culture volumes were used for Western blot analysis probed with 









3.3.3 Recombinant tpSTK1 Substrate Specificity  
A recombinant tpstk1 gene was constructed that encoded a histidine-tagged 
derivative of tpSTK1. Recombinant tpSTK1 (Appendix G) was expressed in E. coli, 
solubilized from inclusion bodies (using 8 M urea), and purified to homogeneity by 
immobilized metal affinity chromatography (Figure 3.8). The purified protein was 
subjected to conditions that promote protein refolding (see section 2.13.2 for 












Figure 3.8. Expression and isolation of recombinant tpSTK1
97
. Coomassie-stained 
SDS-PAG. Identical amounts of cells from an E. coli clone harboring a pPROEX-Htc 
plasmid encoding recombinant tpSTK1 were loaded before (-) and after 3 hours of 
induction with IPTG (+). After cell lysis equal aliquots of the 23,000g supernatant 
(soluble) and pellet (inclusion bodies = IB) were loaded. After solubilization of the 
inclusion bodies with urea, adsorption of the solubilize material to Ni-NTA agarose, and 
refolding on the column, the majority of recombinant tpSTK1 eluted with 200 mM 







Radioactive kinase assays in the presence of [γ-
32
P]-ATP revealed that 
recombinant tpSTK1 phosphorylates three of the four recombinant silaffins (rSil3, rSil1L, 
and rSilC) tested (Figure 3.9 A). Recombinant silaffin rSilN was not phosphorylated by 
recombinant tpSTK1, and is the only recombinant silaffin tested to possess an acidic 
isoelectric point (pI = 3) while those of the phosphorylated recombinant silaffins range 
from 8-12 (see Figure 3.9 B). Of the common kinase substrates tested (myelin basic 
protein: MBP, histones I and II: HisI and HisII, dephosphorylated casein: d. Cas.)
111
, the 
only one not phosphorylated by recombinant tpSTK1 was dephosphorylated casein 
which, like rSilN, has an acidic isoelectric point (pI = 3.5) whereas the other commercial 
kinase substrates have isoelectric points between 10 and 12. Bovine serum albumin 
(BSA) and lysozyme were also tested in the assays but neither substrate was 
phosphorylated by tpSTK1 even though lysozyme has a basic isoelectric point of 11.4. 
These results indicate that tpSTK1 strongly prefers substrates with basic isoelectric points 
(pI > 7). However, pI appears not to be the only criterion for phosphorylation by tpSTK1, 
as demonstrated by the lack of activity with lysozyme.  
To provide a quantifiable, rapid, non-radioactive method to detect the 
phosphorylation activity of recombinant tpSTK1, a luminescence-based kinase assay
 
that 
measures ATP consumption was employed
99
. The data obtained from the luminescence 







































Figure 3.9. Phosphorylation activity of recombinant tpSTK1 with recombinant 
silaffins (rSilN, rSilC, rSil3, and rSil1L) and commercial proteins as substrates. A, 
SDS-PAGE analysis of recombinant tpSTK1 phosphorylation activity in the presence of 
2 µCi [γ-
32
P] ATP and 0.10 mg/mL substrate protein. B, Luminescence-based kinase 
assay
99
 with 0.10 mg/mL substrate protein. Each measurement was repeated at least three 
times. RLU, relative luminescence units. Lys- Lysozyme, His-Histone, MBP- Myelin 
Basic Protein, d. Cas- dephosphorylated casein, BSA- bovine serum albumin. The 











3.3.3.1 Recombinant silacidin substrates 
In addition to the recombinant silaffin and commercial protein substrates, 
silacidin substrates were tested in the luminescence-based kinase assays using 
recombinant tpSTK1. Silacidin
62 
had not been identified when performing the radioactive 
kinase assays that included recombinant tpAK1; therefore, the phosphorylation activity of 
recombinant tpAK1 with silacidin as the substrate has not been tested. The first silacidin 
substrate tested for phosphorylation by recombinant tpSTK1 was a synthetic 19-mer 
peptide (SDESEESEDSVSSEDEDWW; pI 2.8) corresponding to a 17 amino acid 
fragment of silacidin A (see Appendix H). As a positive control, a 19-mer fragment 
derived from the silaffin gene sil1, R5 was utilized in the kinase assays because of its 
basic isoelectric point (pI 11.6) and the fact that rSilC (a recombinant protein derived 
from the same gene) was phosphorylated. The activity of recombinant tpSTK1 was 
negligible for both R5 and Sic1 peptides at the standard substrate concentration of 10 µg. 
However, at 10-fold increased substrate concentrations, recombinant tpSTK1 
phosphorylation activity on R5 was comparable to activities with recombinant silaffin 
rSilC as a substrate (Figure 3.10 black bars), whereas Sic1 was not phosphorylated. These 
results are consistent with the preference of tpSTK1 for basic substrates but it is also 


















Figure 3.10. Phosphorylation activity of recombinant tpSTK1 with synthetic 
peptides (R5 and Sic1) and recombinant silacidin substrates. Kinase activity with 
silaffin peptide R5 (pR5) and silacidin peptide Sic1 (pSic1) at normal (0.1 mg/mL) and 




Since recombinant tpSTK1 prefers protein substrates, efforts were made to purify 
a full length silacidin protein that could be used in tpSTK1 kinase assays. The first 
silacidin construct that was designed encoded the mature silacidin protein with a C-
terminal hexahistidine tag. However, expression of the protein in E. coli was not 
observed. The lack of silacidin expression may be attributed to poor, undetectable yields 
of the protein being produced by the cells. One method to improve the yield of 
recombinant protein expression is to add an N-terminal tag (e.g. glutathione S-transferase 
and maltose-binding protein)
112
. Since affinity tags, such as those mentioned above, could 
potentially interfere with the functional studies of tpSTK1, recombinant silaffin rSilN 




kDa. 2) Expression of rSilN in E. coli has been achieved. 3) There are no additional 
amino acids (called a linker region) between the cleavage site and rSic that could remain 
on the N-terminus of rSic. 4) rSilN was not phosphorylated by recombinant tpSTK1 and 
therefore should not contribute to any observed phosphorylation activity on the fusion 
protein. Recombinant protein rSilNH10-rSic (with the N-terminal protein rSilN possessing 
a C-terminal decahistidine tag, see Appendix I) was expressed and purified from E. coli 
(Figure 3.11 A and B). Due to the presence of the methionine, the mature recombinant 
silacidin protein carrying no additional amino acids can be cleaved from rSilNH10 with 
cyanogen bromide (which cleaves on the carboxy side of methionine residues) (Figure 
3.11 A). To separate rSic from rSilNH10 and from uncleaved or partially cleaved rSilNH10-
rSic, immobilized metal affinity chromatography was employed yielding pure rSic in the 
flow through fraction (FT) as rSic lacks a histidine tag and cannot bind to a Ni-NTA 
column. In the luminescence based kinase assays, neither rSilNH10-rSic nor the purified 
rSic was phosphorylated by tpSTK1, likely due to the acidity of the substrates (pI = 3.8 
























Figure 3.11. Phosphorylation activity of tpSTK1 with recombinant silacidin 
substrates rSilNH10rSic and rSic. A, Schematic of cleavage of rSilN10rSic with cyanogen 
bromide (CNBr) to yield the individual proteins. B, Coomassie-stained SDS-PAG. S: 
molecular mass standard. IPTG: Identical amounts of cells from an E. coli clone 
harboring plasmid pET28a/rSilNH10-rSic were loaded before (-) and after 3 hours (+) of 
induction with IPTG. rSilNH10-rSic: Silaffin-silacidin fusion protein after purification by 
IMAC. CNBr: Silaffin-silacidin fusion protein after CNBr treatment. Ni-NTA: CNBr 
fragments of rSilNH10-rSic that did not bind (FT) and did bind (eluate) to Ni-NTA resin. 
C, Luminescence-based kinase assay with 0.10 mg/mL substrate protein. Each 
measurement was repeated at least three times. RLU, relative luminescence units. rSil3 







3.3.3.2 Hydrogen fluoride treated native silaffin substrates 
As silaffins possess numerous posttranslational modifications, the enzymes 
involved in applying the modifications are likely synergistic (i.e. the action of one 
enzyme may promote or enhance the activity of another enzyme). To test whether the 
phosphorylation of silaffins by tpSTK1 is enhanced by the presence of a posttranslational 
modification, hydrogen fluoride (HF) treated native silaffins (tpSil3-HF, tpSil1/2L-HF, 
tpSil1/2H-HF) were used in kinase assays. HF treatment removes O-linked 
posttranslational modifications such as O-linked glycosylation and phosphate moieties
113
. 
The HF treated silaffins still contain their modified alkylated lysine residues that are 
resistant to HF
58-59,61
. In the luminescence-based kinase assays phosphorylation of the HF 
treated silaffins by recombinant tpSTK1 was observed, albeit to a significantly lesser 
extent than the phosphorylation of recombinant silaffins rSil1L and rSil3. (Figure 3.12). 
This result showed that recombinant tpSTK1 phosphorylation is hindered by the presence 
of the modified alkylated lysine residues. This may be evidence that protein 

























Figure 3.12.Recombinant tpSTK1 phosphorylation activity with HF-treated native 
silaffins. Kinase assays with 0.1 mg/mL T. pseudonana HF-treated silaffins (Sil3-, Sil1/2, 
Sil1/2-HF) contain posttranslational modifications and the activity of tpSTK1 on these 
substrates was compared to the activities with recombinant silaffins rSil1L and rSil3. HF 
treated silaffins still contain modified lysine residues. Each measurement was repeated at 
least three times. RLU, relative luminescence units.  
 
 
3.3.4 Requirements for recombinant tpSTK1 activity 
3.3.4.1 Co-substrates and co-factors  
Recombinant tpSTK1 utilizes ATP for its phosphorylation activity. However, 
kinases, such as casein kinase II, can also hydrolyze GTP
68,79
. To test if recombinant 
tpSTK1 utilizes GTP as its co-substrate, GTP was added to the kinase reaction mixture at 
different ratios to ATP concentration. Since the luminescence assay only measures ATP 
consumption, a decrease in relative luminescence in the presence of GTP would be 
indicative of the kinase being able to also hydrolyze GTP.  With rSil3 as the substrate the 
kinase activity remains unchanged at all GTP:ATP ratios tested, demonstrating that 






) are typically used as co-factors by kinases in protein phosphorylation
68
. 
Recombinant tpSTK1 requires a divalent cation co-factor for phosphorylation of 
recombinant silaffins (Figure 3.13 B). To fulfill the divalent cation requirement for its 
activity, recombinant tpSTK1 preferred Mg
2+ 
to any of the other divalent cations tested in 
the kinase assays (Figure 3.13 B). Negligible amounts of kinase activity were detected in 




 (in the luminescence based assays). In the presence of Mn
2+
, 
recombinant tpSTK1 is moderately active, exhibiting nearly 50 % of the full 









































Figure 3.13. Co-factor dependence and pH stability of recombinant tpSTK1
97
. A, 
Kinase activity with rSil3 in the presence of ATP and increasing concentrations of GTP 
(molar ratios of the nucleotides are indicated). The consumption of ATP was not affected 
by the presence of GTP indicating that GTP cannot replace ATP as a co-substrate for 
recombinant tpSTK1 (note: GTP cannot substitute for ATP in the luciferase-dependent 
reporter reaction
99
). B, Metal-ion dependence of kinase activity. After refolding, 
recombinant tpSTK1 was incubated under kinase reaction conditions in the absence or 
presence of 10 mM of the indicated cation (no other polyvalent metal ions were present). 
C, Kinase activity in different buffers ranging from pH 5.0 – 9.0. The concentration of 
Mg
2+ 
in the sodium phosphate citrate buffers was 10x normal concentration to yield 
comparable activities. Each measurement was repeated at least three times. RLU, relative 









3.3.4.2 pH dependence 
As silaffin phosphorylation takes place within the endomembrane system of diatoms, 
the ability of recombinant tpSTK1 to phosphorylate rSil3 was tested at different pH 
levels that correspond to the known pH inside different intracellular compartments (i.e. 
endoplasmic reticulum (ER): pH 7.0-7.4
114-116
, Golgi: pH 6.1-6.7
114-116
, Silica Deposition 
Vesicle (SDV): pH < 7
117
). Recombinant tpSTK1 is only active in a narrow pH range, 
from 7-8, in Tris based buffers (Figure 3.13 C). In the phosphate/citrate buffer system, 
using the same amount of magnesium as in the kinase assay buffer (10 mM), no kinase 
activity is observed (data not shown). It is possible that the citrate in the buffer chelates 
the magnesium ions, making them unavailable for the kinase to use for its activity. To 
compensate for the loss of magnesium due to complexation with citrate, a 10 fold 
increase in the Mg
2+ 
concentration was included in the kinase buffer and resulted in 
significant kinase activity at pH 7 and 8. Thus, recombinant tpSTK1 is active in the 
neutral to slightly basic pH range in various buffers. Since the ER is neutral and the Golgi 
and SDV are more acidic, one can speculate that if tpSTK1 is a membrane bound kinase, 
it is likely to reside in the ER. 
 
3.4 Purification and chemical analysis of phosphorylated recombinant silaffins 
 
3.4.1 RP-HPLC purification and phosphate release determination 
To determine the amount of phosphate incorporated into the recombinant 
silaffins, the recombinant tpSTK1-phosphorylated proteins rSil3 and rSilC were purified 




Phosphorylated rSil3 (rSil3-P) and rSilC (rSilC-P) exhibited significant downshifts in 
their RP-HPLC elution times consistent with a decrease in hydrophobicity due to 























Figure 3.14. RP-HPLC of phosphorylated recombinant silaffin substrates
97
. Analysis 
after incubation of A, rSil3 or B, rSilC with tpSTK1 in the presence (+ATP) and absence 
of (-ATP).  
 
 
To determine the number of phosphates incorporated on the recombinant silaffins 
by recombinant tpSTK1, a colorimetric phosphate release assay was performed. The 
dried protein residues are acid-hydrolyzed to release the phosphate from the protein 
backbone. A dye (malachite green in this case) then binds to the released phosphate under 




the phosphate content calculated from a inorganic phosphate standard curve (Figure 
3.15). As controls, ATP and glycerol phosphate were subjected to phosphate content 
chemical analysis and the number of phosphates detected for ATP and glycerol phosphate 
were 2.9 - 3.1 and 0.8 - 1.0 mol phosphate per mole protein, respectively (Table 3.3). 
These values are consistent with the known phosphate content of ATP (3 phosphates per 
molecule) and glycerol phosphate (1 phosphate per molecule), demonstrating the 
accuracy of the applied method. Chemical analysis
 
of rSil3-P and rSilC-P detected 2.8 -
3.1 and 0.8 - 1.1 mol phosphate per mole of protein, respectively (Table 3.3). The number 
of phosphates incorporated on the recombinant silaffins is quite low given that native 









Figure 3.15. Quantification of inorganic phosphate using the malachite green 









Table 3.3. Analysis of phosphate content in silaffins and reference compounds
97
. 
Phosphorylated silaffin rSil3 (rSil3-P) and phosphorylated silaffin rSilC (rSilC-P) were 
purified by RP-HPLC and quantified as described in section 2.20.1. ATP (contains 3 
phosphate residues per molecule) and glycerophosphate (GlcP; contains 1 phosphate 
residue per molecule) were used as purchased. Inorganic phosphate obtained after 
hydrolysis was calculated according to the inorganic phosphate reference shown in 















3.4.2 Phosphoamino acid analysis 
Phosphoamino acid analysis of RP-HPLC-purified rSil3-P detected 
phosphoserine; consistent with the prediction that tpSTK1 is an S/T kinase (Figure 3.16). 
This finding is biologically relevant as phosphoserine is also present in the corresponding 
native silaffin, tpSil3, isolated from T. pseudonana. Native tpSil3 also contains 
phosphothreonine and O-sulfated serine (an amino acid artificially generated during acid 
hydrolysis of tpSil3), which are absent from recombinant tpSTK1-phosphorylated rSil3. 
 








0.1 0.016 0.28 2.8 
0.75 0.152 2.30 3.1 
1.1 0.216 3.24 2.9 
rSilC-P 
0.17 0.012 0.14 0.8 
1.26 0.112 1.40 1.1 
1.85 0.178 1.79 1.0 
GlcP 
0.50 0.013 0.39 0.8 
2.00 0.113 2.01 1.0 
5.00 0.272 4.36 0.9 
ATP 
0.25 0.046 0.73 2.9 
0.50 0.102 1.56 3.1 





















Figure 3.16. Chemical analysis of phosphorylated substrates
97
. Phosphoamino acid 
analysis by anion exchange HPLC of tpSTK1-phosphorylated rSil3 (rSil3-P) and native 
silaffin tpSil3. The peak labeled with an asterisk contains O-sulfated serine which was 
artificially generated during tpSil3 hydrolysis (N. Poulsen and N. Kröger, unpublished 
result). As a reference the chromatogram of a mixture of the standard amino acids 
phosphotyrosine (Yp), phosphothreonine (Tp) and phosphoserine (Sp) is shown. 
 
 
3.5 tpSTK1 homolog, tpSTK2 
 
 
3.5.1 Primary sequence alignments 
The low number of incorporated phosphates and the lack of phosphothreonine in 
rSil3 treated with recombinant tpSTK1 suggest that other kinases may be involved in the 
phosphorylation of silaffins. A BLAST
107
 search of the NCBI database revealed 
significant sequence alignments (e values < 2e-7) of tpSTK1 to more than 50 proven or 
predicted serine/threonine kinases from a broad range of organisms (including other 




relatively high e-values (between 2e-10 to 8e-7), while three predicted diatom kinases, 
tp7188 (GenBank# ACI64649.1) from T. pseudonana, and pt45008 (GenBank# 
EEC49800.1) and pt32914 (GenBank# EEC50886.1) from Phaeodactylum tricornutum 
exhibited much lower e-values (3e-86, 1e-71, and 5e-44, respectively), and thus much 
higher sequence similarity (Figure 3.17). The three tpSTK1-like diatom kinases each 
contain a predicted kinase domain in the C-terminal part of the protein exhibiting 26.0 % 
- 28.8 % amino acid sequence conservation amongst each other and tpSTK1. In addition, 
the positions of 44.4% - 48.0 % of the amino acid residues within the kinase domains are 









Figure 3.17. Primary structures of tpSTK1 and related proteins
97
. Alignment of 
tpSTK1 with predicted protein tp7188 (GenBankTM accession number ACI64649.1) 
from T. pseudonana and predicted proteins pt45008 and pt32914 (GenBankTM accession 
numbers EEC49800.1 and EEC50886.1) from P. tricornutum. The alignment was 
performed using the ClustalW2 program
118
. Amino acids that are conserved among all 
(red), three (green), and two (yellow) sequences are highlighted. The predicted kinase 




3.5.2 Substrate specificity of recombinant tpSTK2-KD 
The T. pseudonana tpSTK1 homolog tp7188, denoted in the following as tpSTK2, 
was investigated to determine its involvement, if any, in silaffin phosphorylation. Since 
the full length cDNA sequence of the tpstk2 gene predicted in the T. pseudonana genome 
database, could not be confirmed by RACE-PCR and RT-PCR (Appendix J), the region 




RACE-PCR and RT-PCR) was fused to a hexahistidine tag, expressed in E. coli and 
solubilized from inclusion bodies. Recombinant tpSTK2-KD (33 kDa, pI = 6.03, 
Appendix K) was purified to homogeneity by immobilized metal affinity chromatography 
under denaturing conditions (8 M urea) (Figure 3.18) then subjected to on-column 
refolding under the same conditions used to yield active recombinant tpSTK1 (see section 














Figure 3.18. Expression and isolation of recombinant tpSTK2 Kinase Domain. 
Coomassie-stained SDS-PAG. Identical amounts of cells from an E. coli clone harboring 
a pET16b plasmid encoding recombinant tpSTK2-KD were loaded before (-) and after 3 
hours of induction with IPTG (+). After solubilization of the inclusion bodies with urea, 
adsorption of the solubilized material to Ni-NTA agarose, and refolding on the column, 
the majority of recombinant tpSTK2-KD eluted with 200 mM imidazole (immobilized 
metal affinity chromatography = IMAC). 
 
 
 Recombinant tpSTK2-KD was tested for its activity with the recombinant 
silaffins, recombinant silacidin and the commercial proteins as substrates using the 
luminescence based kinase assays. Recombinant tpSTK2-KD only exhibited kinase 




tpSTK2-KD phosphorylates the other substrates only after previous phosphorylation of 
the substrates with another kinase. For example, casein kinase I is active on recombinant 
phosphophoryn only after prior phosphorylation with casein kinase II
76
. To test whether 
tpSTK2-KD is active on phosphorylated proteins, the substrates were first incubated with 
tpSTK1 for one hour, and then tpSTK2 was added and the reaction mixtures were 
incubated for an additional hour. The phosphorylation of the substrates due to 
recombinant tpSTK2 activity was calculated by subtracting the tpSTK1 activity. Most of 
the substrates were not phosphorylated by recombinant tpSTK2-KD, even after prior 
phosphorylation with tpSTK1 (Figure 3.19, pink bars). However, the activity of 
recombinant tpSTK2-KD on phosphorylated myelin basic protein (MBP-P) increased by 
42 %, suggesting a synergistic effect of tpSTK1 and tpSTK2 on myelin basic protein. 
Although tpSTK2-KD did not phosphorylate any of the recombinant silaffins or 








Figure 3.19. Phosphorylation activity of recombinant tpSTK2-KD with recombinant 
silaffins (rSilN, rSilC, rSil3, and rSil1L), recombinant silacidin (rSic), and 
commercial proteins as substrates. Black bars, Luminescence-based kinase assays with 
0.10 mg/mL substrate protein (black bars). Grey bars, Substrates were phosphorylated by 
tpSTK1 first before tpSTK2-KD activity assays. TpSTK1 activity has been subtracted to 
yield only the kinase acitivty due to tpSTK2-KD. Each measurement was repeated at 
least three times. RLU, relative luminescence units. Lys- Lysozyme, His-Histone, MBP- 





3.6 Intracellular location of native tpSTK197 
 
3.6.1 TpSTK1-24:  N-terminal ER targeting peptide or transmembrane domain? 
As mentioned earlier, current sequence analysis tools cannot unequivocally 
distinguish between a transient targeting peptide for co-translational ER import and a 
permanent membrane anchor
110
. The ability of the first 24 amino acids of tpSTK1 to act 
as N-terminal ER signal peptide was evaluated by observing (using microscopy) the 




(GFPDDEL) the N-terminal tpSTK1 peptide in T. pseudonana. The tetrapeptide D-D-E-L, 
which is the ER retention signal from the T. pseudonana ER-resident molecular 
chaperone BiP (binding protein)
119
, was added at the C-terminus of the GFP in both 
constructs to prevent its secretion into the medium by retaining it in the ER. The GFPDDEL 
protein that was expressed without an N-terminal extension exhibited a cytosolic 
localization pattern whereas the GFPDDEL fused to STK1-24 was located in a clamp-like 
structure that was associated with the chloroplast (Figure 3.20 top). A similar localization 
pattern was observed with GFP fused to the signal peptide of the ER resident protein, BiP 
(BiP1-27GFP). As diatom chloroplasts are tightly surrounded by ER membranes
120
, the 
chloroplast-associated clamp-like structures containing STK1-24GFPDDEL and BiP1-27GFP 
may represent sub-compartments of the ER.  
During maturation, the N-terminal signal peptides of proteins destined for the ER 
are cleaved off by endogenous signal peptidases, a characteristic of an N-terminal signal 
peptide that is not shared with transmembrane domains. Western blot analysis revealed 
that the apparent molecular mass of STK1-24GFPDDEL in T. pseudonana was identical to 
that of the cytosolically expressed GFPDDEL indicating that the N-terminal STK1-24 part 
was cleaved off (Figure 3.20 bottom). The same is true for the BiP1-27GFP fusion protein 
as the resulting protein, GFP, was smaller in apparent molecular mass than GFP carrying 





















Figure 3.20. Intracellular processing and localization of GFP fusion proteins
97
. For 
names and composition of the GFP fusion proteins refer to section 3.22. Top, Confocal 
fluorescence micrographs of individual T. pseudonana cells expressing the GFP fusion 
proteins indicated in the top panel. The red color is caused by autofluorescence of the 
chloroplasts. Scale bars = 2 µm. Confocal images taken by Nicole Poulsen. Bottom, 
corresponding Western blot with anti-GFP antibodies (0.5 µg/mL). In each lane, whole 
cell lysates of T. pseudonana expressing the indicated GFP fusion protein were loaded. 
After removal of the N-terminal signal peptide from BIP1–39GFPDDEL, 12 amino acids 
derived from the mature BiP sequence remain attached to the N terminus of GFP.  
 
 
A second BiP-GFP fusion protein contained amino acids 1-39 and the C-terminal 
ER-retention signal of BiP. Removal of the signal peptide during intracellular maturation 
was expected to generate a GFP fusion protein that contains 12 and 16 amino acids more 
than the proteins derived from STK1-24GFPDDEL and BiP1-27GFP, respectively. Indeed, 
Western blot analysis confirmed that the BiP1-39GFPDDEL had the highest molecular mass 
of all GFP fusion proteins that were analyzed (Figure 3.20 bottom). Interestingly, the 
BiP1-39GFPDDEL derived protein exhibited an ER-like localization pattern suggesting that 
the additional amino acids derived from mature BiP have a strong influence on the 




acids 1-24 of tpSTK1 function as a cleavable signal peptide for import into the ER and 
not a permanent membrane anchor domain. 
 
3.6.2 Localization of native tpSTK1  
3.6.2.1 GFP tagged tpSTK1  
The signal peptides of tpSTK1 and BiP targeted GFP to the chloroplast associated 
clamp-like structures (that may be ER sub-compartments), yet only a few additional 
amino acids influenced the localization pattern of the BiP protein. Therefore, additional 
targeting signals present in the full length proteins must be present to direct the proteins 
out of the ER sub-compartments and into other areas within the cell. To determine the 
intracellular location of native tpSTK1, the full length tpSTK1 gene fused to GFP fusion 
gene was constructed and introduced into T. pseudonana cells. For comparison, the full 
length ER BiP protein fused to GFP was also introduced into T. pseudonana. Although 
the cells expressed tpSTK1-GFP, as evident by the detection of an 85 kDa band on a 
Western blot probed with anti-GFP IgGs (Figure 3.21 A), no GFP-fluorescent 
transformants were obtained for tpSTK1-GFP. If tpSTK1 was located in the ER, the 
tpSTK1-GFP fusion protein would be expected to show a reticulate-like localization 
pattern that is observed with the BiP-GFP fusion protein (Figure 3.21 B). One possible 
reason for the lack of GFP fluorescent transformants may be improper or partial folding 
of the fusion protein. However, placing the tag on the N-terminal end of the protein may 
promote proper folding. Therefore, a fusion construct was generated that placed the GFP 
near the N-terminus of the presumed mature tpSTK1 (Figure 3.21 C). However, no GFP-















Figure 3.21. TpSTK1-GFP fusion constructs expressed in the diatom T. pseudonana. 
A, Western blots with anti-GFP antibodies (0.5 µg/mL) of cells expressing tpSTK1 with a 
C-terminal GFP (STK-GFP) and an N-terminal GFP (GFP-STK1). Wild type cells 
(Tpwt) were included as a control. Equal aliquots of cells were loaded. B, 
Epifluorescence micrograph of a T. pseudonana cell expressing the full-length BiP 
protein fused to a C-terminal GFP tag with the diatom ER retention tetrapeptide (DDEL). 
Scale bar = 2 µm.    
 
 
3.6.2.2 Biochemical localization of native tpSTK1  
As GFP tagging of tpSTK1 was unsuccessful, a biochemical approach was 
pursued for identifying the intracellular localization of native tpSTK1. T. pseudonana 
cells were gently lysed with glass beads and the lysate separated into three fractions by 
differential centrifugation: P1 (16,000g pellet), P2 (100,000g pellet), and S2 (100,000g 
supernatant). S2 is the cytosolic fraction, P1 contains non-lysed cells, cell walls, and ~80 
% of the chloroplasts (estimation based on chlorophyll content), and P2 contains plastid-
depleted cellular membranes. Western blot analysis with anti-tpSTK1 IgG revealed that 
tpSTK1 is predominantly present in the P2 fraction and virtually absent from the cytosol. 




experimental details) show that tpSTK1 is not secreted into the medium (Figure 3.22 
Left). Given the intimate association of the ER with diatom plastids, it is likely that 
proteins within the chloroplast associated-clamplike structure (CA-CLS) would co-
localize with diatom plastids. However, the localization of mature tpSTK1 with plastid-
depleted cellular membranes suggests that tpSTK1 does not reside in the CA-CLS. The 
P2 membranes were fractionated by sucrose density gradient centrifugation (optimized to 














Figure 3.22.  Intracellular location of native tpSTK1 in T. pseudonana wild type 
cells
97
. Left, Western blot probed with anti-tpSTK1 IgG (0.2 µg/mL) showing the 
distribution of native tpSTK1 in subcellular fractions and the culture medium. Equal 
aliquots of whole cell lysate (Cells), cell culture medium (sec.), and subcellular fractions 
(P1, P2, S2) were subjected to SDS-PAGE. Right, Schematic of sucrose density gradient. 




Each fraction was analyzed for the presence of tpSTK1, protein and chlorophyll 
content, and the activities of marker enzymes for ER (NADH: cytochrome c reductase = 
CCRase), mitochondria (cytochrome c oxidase = COx), Golgi apparatus (IDPase), and 




enzyme assays fraction F4 contains the majority of the ER membranes (71 % of total 
CCRase activity), almost all of the Golgi membranes are present in fraction F5 (74 % of 
total IDPase activity), and combined fractions F6 and F7 contain the majority of 
mitochondria (79 % of total COx activity) and plasma membrane (96 % of total 
vsATPase activity) (Table 3.4).  
 
 
Table 3.4. Enzyme activities and protein and chlorophyll content in subcellular 
fractions of T. pseudonana
97
. The listed numbers represent averages from three 
independent experiments. The number for the highest activity of a particular enzyme is 
shown in bold. IDPase, inositol diphosphatase; CCRase, cytochrome c reductase; COx, 
cytochrome c oxidase; vsATPase, vanadate-sensitive ATPase; Chl, chlorophyll; n.d., not 
determined.       




Western blot analysis of the same gradient fractions using anti-tpSTK1 antibodies 
detected tpSTK1 mainly in fraction F4, and to a smaller extent in fraction F3, but not in 
any other fraction (Figure 3.23). The fact that the distribution of tpSTK1 within the 
sucrose gradient perfectly paralleled the distribution of ER membranes indicates that the 





(nmol cyt c 
red/min) 
COx 







(mg) Fraction  
S2 n.d. n.d. n.d. n.d. 1.31±0.09 0.04±0.01 
P1 n.d. n.d. n.d. n.d. 0.79±0.06 2.45±0.13 
P2 n.d. n.d. n.d. n.d. 1.20±0.10 0.65±0.08 
F1 + F2 0.04±0.01 0.07±0.03 0.04±0.02 0.01±0.00 0.41±0.03 0.11±0.03 
F3 0.05±0.02 0.33±0.02 0.03±0.01 0.01±0.00 0.14±0.01 0.06±0.02 
F4 0.34±0.03 1.74±0.04 0.03±0.00 0.01±0.01 0.21±0.01 0.03±0.02 
F5 1.44±0.02 0.04±0.03 0.11±0.04 0.04±0.02 0.19±0.02 0.02±0.01 



















Figure 3.23. Distribution of tpSTK1 in subcellular membrane fractions
97
. A, Western 
blot probed with anti-tpSTK1 IgG (0.2 µg/mL) of native tpSTK1 in membrane fractions 
from density sucrose gradient centrifugation. Equal aliquots of sucrose gradient fractions 
F1–F7 were loaded. B, Chymotrypsin treatment of intact membranes. Silver-stained SDS 
PAG. F4 membranes (10 µg/mL total protein) were incubated for 1 hour at 4 
o
C in the 
absence (-) or presence (+) of 0.3 mg/mL chymotrypsin. C, Orientation of native tpSTK1 
in F4 membranes from T. pseudonana. Protease accessibility test. Equal amounts of 
membranes from fraction F4 were incubated in the absence (-) or presence (+) of the 







3.6.3 Protease Accessibility Assays 
As the silaffins are transported through the endomembrane system, they are not 
exposed to the cytosol. Therefore, tpSTK1 must reside within the lumen of the ER 
membranes if it is to interact with silaffins in vivo. To determine whether tpSTK1 is 
localized on the cytosolic or the luminal side of membranes, protease accessibility 
experiments were performed with the membranes isolated from fraction F4. Treatment of 
the membranes with chymotrypsin resulted in degradation of several major protein 




CCRase (Table 3.5). However, CCRase activity was completely disrupted when the 
membranes were detergent solubilized prior to chymotrypsin treatment. These results 
indicated that the surfaces of the isolated ER membranes were correctly oriented (“inside-
in”). To test the accessibility of tpSTK1 to proteases, intact F4 and detergent-solubilized 
membranes were incubated with 1.0 µg of chymotrypsin for one hour on ice. If tpSTK1 is 
in the lumen of the ER membranes, then it should be protected from protease degradation 
in the same manner as was observed for CCRase. Western blot analysis of chymotrypsin-
treated intact F4 membranes revealed that tpSTK1 is inaccessible to protease digestion. 
Degradation of tpSTK1 is only observed when the membranes are solubilized by the 




Table 3.5. Protease accessibility of CCRase activity in F4 membranes
97
. The activity 
of this ER-located enzyme was measured after treatment of intact and detergent-
solubilized (1 % w/v Igepal) F4 membranes with 1.0 mg/mL chymotrypsin. The listed 
numbers represent the averages from three independent experiments. 












3.6.4 Amount of native tpSTK1 in the ER 
To estimate the amount of native tpSTK1 in the ER membranes, Western blot 
analysis comparing the intensity of various amounts of F4 membranes to known 
 
CCRase 
(nmol cyt cred/min) 
intact membranes 1.81 
intact membranes + chymotrypsin 1.75 






concentrations of recombinant tpSTK1 was performed. The intensity of the signal of 
native tpSTK1 in the F4 fraction containing 10 µg of total protein is almost the same 
intensity as that observed from 0.05 µg of recombinant tpSTK1 (Figure 3.24). Based on 
this observation, it is estimated that 0.5 % of the total protein content in the ER fraction is 









Figure 3.24. Western blot for estimation of native tpSTK1 content of F4 
membranes
97
. Recombinant tpSTK1 was isolated by IMAC and gel extraction after 
SDS-PAGE. Protein concentrations were determined using the BCA assay
94
. The 
Western blot was probed with 0.2 μg/mL anti-tpSTK1 IgG. 
 
 
3.7 TpSTK2 intracellular location 
 
3.7.1 Location of native tpSTK2 in cellular membrane fractions 
Using the established biochemical fractionation techniques, the intracellular 
location of tpSTK2 was explored. A polyclonal antiserum was produced against 




antiserum by dual affinity chromatography on a recombinant tpSTK2-KD-loaded column 
followed by protein G-agarose. The anti-tpSTK2 IgGs detected a protein of apparent 
molecular mass of 90 kDa in a T. pseudonana whole cell lysate (Figure 3.25 A). 
Although the full length cDNA sequence of tpSTK2 is unknown, the gene model in the T. 
pseudonana encodes for a protein with a predicted molecular mass of 94 kDa. Therefore, 
the 90 kDa protein band detected in the diatom cells is presumed to be native tpSTK2. 
However, other bands estimated at 80, 50, 44, 40 kDa are detected by anti-tpSTK2 that 
could be degradation products of tpSTK2. Western blot analysis using anti-tpSTK2 IgG 
revealed that tpSTK2 is mainly present in the cytosolic fraction (S2) (Figure 3.25 B top), 
but a significant amount is also present in membrane fraction (P2). TpSTK2 is not 
secreted into the medium. Western blot analysis with anti-tpSTK1 IgG on the same 
fractions revealed that the localization of tpSTK1 with cellular membranes was consistent 










Figure 3.25. Intracellular location of native tpSTK2 and tpSTK1 in T. pseudonana 
wild type cells. A, Western blots probed with anti-tpSTK2 IgG (0.3 µg/mL) and 
preimmune IgG (0.3 µg/mL) that were isolated from the same rabbit. Lanes labeled 
“rSTK2”contained 200 ng of purified recombinant tpSTK2-KD; lanes labeled “Cells” 
contained lysates from 1.3×10
6
 T. pseudonana cells. B, Western blots probed with anti-
tpSTK2 (0.3 µg/mL) (Top) or anti-tpSTK1 IgG (0.2 µg/mL) (Bottom) showing the 
distribution of native tpSTK1 and tpSTK2 (the 86 kDa band) in subcellular fractions and 
the culture medium. Equal aliquots of whole cell lysate (cells), cell culture medium 
(sec.), and subcellular fractions (P1, P2, S2) were subjected to SDS-PAGE. 
 
 
Since the majority of tpSTK2 was present in the cytosolic fraction (S2), marker 
enzyme assays were performed with the cytosolic fraction to determine whether any 
membrane bound proteins (i.e. the marker enzymes) are present. The majority of the 
marker enzyme activity observed in S2 is from IDPase, the Golgi marker protein. There 
is some ATPase activity (plasma membrane) but virtually no activity from CCRase (ER 
marker) or COx (mitochondrial marker). The 2.6-fold more IDPase activity in the 
cytosolic S2 fraction than in the Golgi fraction F5 (Table 3.6) indicates that the Golgi 




Table 3.6. Enzyme activities in T. pseudonana cytosolic fraction S2 and membrane 
fraction F5. The listed numbers represent averages from three independent experiments. 
IDPase, inositol diphosphatase; CCRase, cytochrome c reductase; COx, cytochrome c 





Despite the small amount of tpSTK2 in the P2 membranes (relative to the 
cytosolic fraction), the membranes were fractionated by sucrose density gradient 
centrifugation and each fraction was analyzed by Western blot for the presence of 
tpSTK1 and tpSTK2. As observed previously, tpSTK1 is present mainly in F4 and to a 
smaller extent in F3 (Figure 3.26 bottom), co-localizing with the ER membranes. 
TpSTK2, however, is mainly present in F5, the Golgi containing membrane fractions, and 
to a lesser extent in F6 which contains mitochondria and plasma membranes but virtually 
no Golgi membranes (Figure 3.26 top). Although some tpSTK2 is present in the F6 
fraction, the majority of tpSTK2 (possibly ~90 %) is distributed to the Golgi membrane 
fraction F5 and to the cytosolic fraction S2 which closely follows the distribution of the 





 S2 F5 
IDPase (nmol Pi/sec) 3.48 ± 0.11 1.34 ± 0.06 
NADH:CCRase (nmol cyt c red/min) 0.13 ± 0.11 0.03 ± 0.11 
COx (nmol cyt c ox/min) 0.07 ± 0.11 0.09 ± 0.11 










Figure 3.26. Distribution of tpSTK2 and tpSTK1 in subcellular membrane fractions. 
Western blot probed with anti-tpSTK2 (0.3 µg/mL) (Top) or anti-tpSTK1 IgG (0.2 
µg/mL) (Bottom) of native tpSTK1 and tpSTK2 in membrane fractions from density 




3.7.2 Protease Accessibility Assays 
Protease accessibility assays were performed with the isolated membranes in F5 
to determine if tpSTK2 is in the lumen of the Golgi and thus protected from protease 
degradation. Treatment of the membranes with chymotrypsin resulted in ~20 % loss of 
the total IDPase activity, revealing that some IDPase is exposed to the cytosol. However, 
the remaining 80 % of the total IDPase activity is lost only after the membranes are 
solubilized with detergent, indicating that there are a significant amount of intact Golgi 













Table 3.7. Protease accessibility of IDPase activity in F5 membranes. The activity of 
this Golgi-located enzyme was measured after treatment of intact and detergent-
solubilized (1 % w/w Igepal) F5 membranes with 1.0 mg/mL chymotrypsin. The listed 










Western blot analysis of the intact F5 membranes revealed that nearly 80 - 90 % 
of tpSTK2 was degraded by chymotrypsin (1.0 µg/µL) in one hour (Figure 3.27). 
However, a small amount of tpSTK2 is protected by from protease treatment that is not 
degraded even after a longer incubation (2 hours) with the protease. However, with the 
poor isolation of intact membranes and the presence of some membrane bound tpSTK2, 






Figure 3.27. Orientation of native tpSTK2 in F5 membranes from T. pseudonana
97
. 
Protease accessibility test. Equal amounts of membranes from fraction F5 were incubated 











intact membranes 1.49 
intact membranes +chymotrypsin 1.21 






3.8 Kinase activity in ER and Golgi Membranes 
 
3.8.1 Total kinase activity 
To investigate the phosphorylation of silaffins and silacidin by kinases associated 
with the ER and Golgi apparatus, kinase assays were performed with membranes from 
sucrose gradient fractions F5 (contains Golgi membranes) and F4 (contains ER 
membranes) using recombinant silaffin substrates (rSil1L, and rSil3) and the recombinant 
silacidin. Kinase activity with all substrates was very low with intact membranes (Figure 
3.28, black and grey bars) and at least 10-times higher with detergent-solubilized 
membranes (Figure 3.28, yellow and blue bars), indicating that the kinases acting on 
these substrates are luminal kinases. The kinase activity observed with substrate rSil3 and 
rSil1L was substantially higher with solubilized membranes from fraction F4 (contains 
ER membranes) than from fraction F5 (contains Golgi membranes), whereas the extent of 
rSic phosphorylation was almost identical with solubilized membranes from both 
fractions. Dephosphorylated casein was also tested as a substrate and phosphorylation of 
this substrate was observed from kinases in both ER and Golgi membrane fractions. This 
is consistent with previous reports that have shown that casein-like kinase activities are 









Figure 3.28. Phosphorylation of silaffins rSil3 and rSil1L, silacidin rSic, and 
dephosphorylated casein (Cas.) in subcellular fractions of T. pseudonana containing 
ER (F4) and Golgi (F5) membranes. For each assay equal amounts of membranes (10 
µg of total protein) were used. The concentration of each substrate protein was 0.1 
mg/mL . Kinase activities of intact membranes (-) and membranes solubilized with 1.0 % 
(v/v) Igepal (+) are shown. Each measurement was repeated at least three times and the 





3.8.2 Kinase activity attributed to native tpSTK1 
To determine the contribution of native tpSTK1 to the observed phosphorylation 
activities, kinase assays were performed in the presence of anti-tpSTK1 IgG. Before 
performing antibody inhibition assays with the F4 and F5 membrane fractions it was 
necessary to first determine the amount antibody required to completely inhibit tpSTK1 
activity. To obtain this value, the activity of 100 µg/mL recombinant tpSTK1 on rSil3 
was evaluated in the presence of increasing anti-tpSTK1 concentrations. At antibody 
concentrations ≥ 100 µg/mL, recombinant tpSTK1 (100 µg/mL) is virtually inactive 
(Figure 3.29 A). When the tpSTK1: IgG ratio remains constant (1:2 by mass), 




antibody complexes are stable even at 10-fold dilution. Given that there is about 10 
µg/mL of native tpSTK1 in the F4 fraction, incubating F4 and F5 membranes with 100 
µg/mL of anti-tpSTK1 IgG (20:1 ratio by mass) should be more than sufficient to inhibit 





























Figure 3.29. Inhibition of recombinant tpSTK1 by anti-tpSTK1 IgG in vitro
97
. 
Recombinant silaffin rSil3 was used as substrate protein. A, Kinase activity of 
recombinant tpSTK1 (100 μg/mL) in the presence of increasing concentrations of anti-
tpSTK1 IgG. Virtually complete inhibition of kinase activity (<5 % of maximum kinase 
activity) can be achieved at an antibody concentration of ≥100 μg/mL. B, Kinase activity 
of recombinant tpSTK1 (rSTK1) in the presence of anti-tpSTK1 IgG at a constant 
tpSTK1:IgG ratio (1:2 by mass), but decreasing overall protein concentration. The kinase 
remained virtually inactive at all protein concentrations indicating that the tpSTK1:IgG 




In the presence of anti-tpSTK1 IgGs, the kinase activities of F4 and F5 
membranes with substrates rSic, rSilN, and dephosphorylated casein remained virtually 
unchanged (Figure 3.30). With substrates rSil3, rSilC and rSil1L, the kinase activity of 
F5 membranes did not decrease in the presence of the anti-tpSTK1 IgGs, while the kinase 
activity of F4 membranes decreased by 24 %, 21 %, and 29 %, respectively. Using the 
same concentration of preimmune IgGs instead of anti-tpSTK1 IgGs did not inhibit the 
activities of the kinases present in solubilized membrane preparations from either 
fraction. These data indicated that native tpSTK1 was responsible for about 20 % - 30 % 
of the silaffin kinase activity in the ER lumen and was unable to phosphorylate acidic 
proteins rSilN, rSic, and dephosphorylated casein. The ability of native tpSTK1 to 
phosphorylate basic silaffin substrates and not acidic substrates (including rSic and 
dephosphorylated casein) is in perfect agreement with the phosphorylation activity of 

















Figure 3.30. Inhibition of tpSTK1 activity in subcellular membrane fractions of T. 
pseudonana
97
. Phosphorylation of silaffins (rSil3 and rSil1L) and silacidin (rSic) in 
detergent-solubilized membranes of ER-containing fraction F4 (A) and Golgi-containing 
fraction F5 (B) in the presence (+) or absence (-) of equal concentrations of anti-tpSTK1 
IgG or preimmune IgG. Each measurement was repeated at least three times. RLU, 











3.8.3 Native tpSTK2 kinase activity 
 
Antibody-based inhibition assays (as described for tpSTK1) were used to 
determine the contribution of native tpSTK2 to the observed phosphorylation activities; 
kinase assays were performed in the presence of anti-tpSTK2 IgG. The same amount 
(100 µg/mL) of antibody used to completely inhibit the activity of recombinant tpSTK1 
in vitro was used in these assays. In the presence of the antibodies the kinase activities of 
F4 and F5 membranes remained virtually unchanged with all of the recombinant silaffin 
and silacidin substrates (rSilN, rSil3, rSilC, rSil1L and rSic) tested (Figure 3.31). The 
trivial amount of inhibition observed in the ER fraction with rSil1L as the substrate is 
within error and not attributed to tpSTK2 as tpSTK2 is not present in that fraction. Using 
the same concentration of preimmune IgG instead of anti-tpSTK2 IgG also did not inhibit 
the activities of the kinases present in solubilized membrane preparations from either 
fraction. These data indicate that native tpSTK2 is not a silaffin- (or a silacidin-) 







































Figure 3.31. Inhibition of tpSTK2 activity in subcellular membrane fractions of T. 
pseudonana. Phosphorylation of silaffins (rSil3 and rSil1L) and silacidin (rSic) in 
detergent-solubilized membranes of ER-containing fraction F4 (A) and Golgi-containing 
fraction F5 (B) in the presence (+) or absence (-) of equal concentrations of anti-tpSTK2 
IgG or preimmune IgG. Each measurement was repeated at least three times. RLU, 











Antibody-based inhibition experiments using recombinant tpSTK2-KD and 
myelin basic protein as the substrate revealed that 100 µg/mL of anti-tpSTK2 IgG 
inhibited kinase activity by 61 % (Figure 3.32). As the same concentration of anti-
tpSTK2 did not exert any inhibitory effect on phosphorylation of recombinant silaffin and 
silacidin by F5 membranes, it can be concluded that native tpSTK2 is incapable of 
phosphorylating these substrates.   
 
 
Figure 3.32. Inhibition of recombinant tpSTK2-KD by anti-tpSTK2 IgG in vitro. 
Myelin basic protein was used as substrate protein. Kinase activity of recombinant 
tpSTK2-KD (100 μg/mL) in the presence of increasing concentrations of anti-tpSTK1 
IgG. Inhibition of kinase activity (61 % of maximum kinase activity) can be achieved at 
an antibody concentration of 100 μg/mL, the concentration used for assessing the native 








 CHAPTER 4: DISCUSSION 
 
4.1 The Discovery of a Biomineralization kinase 
 
Given the importance of phosphoproteins in biomineralization, the kinases that 
catalyze their phosphorylation are equally important, yet not a single biomineralization 
kinase had been identified from any organism (including humans!) until now. Of the two 
putative kinases, tpSTK1 and tpAK1, identified from a proteomics study on silica 
formation in the diatom T. pseudonana
65
, only tpSTK1 emerged as a kinase capable of 
phosphorylating silaffin biosilicification proteins in vitro. TpSTK1 is a serine/threonine 
kinase that contains an N-terminal signal peptide for co-translational import into the 
endoplasmic reticulum (ER) where it remains in the lumen of this compartment (see 
Figures 3.20 and 3.22-3.24). Comparable to other abundant ER proteins such as protein 
disulfide isomerase (~ 0.4 % of total protein
121
) and BiP (estimates in the range of 1 % to 
5 % of total protein
122
), tpSTK1 is a relatively abundant ER protein amounting to ~ 0.5 % 
of the total protein (see Figure 3.24). In vitro kinase assays revealed that tpSTK1 only 
catalyzed the phosphorylation of basic recombinant silaffin substrates (i.e. rSilC, rSil3, 
rSil1L, and R5) but not the acidic recombinant substrates, silaffin rSilN and silacidin rSic 
(see Figures 3.9-3.11). Although tpSTK1 phosphorylated the peptide substrate R5, the 
peptide had to be in 10-fold excess for it to be phosphorylated by recombinant tpSTK1, 
which indicates that tpSTK1 prefers proteins over peptides (see Figure 3.10). 
Recombinant tpSTK1 phosphorylation activity requires ATP, not GTP, as a co-substrate 






(see Figure 3.13). Optimal kinase activity of recombinant tpSTK1 was observed in the 
pH range of 7-8, which is consistent with native tpSTK1 operating in the ER (which has a 
pH in the range of 7.0-7.4) (see Figure 3.13). Given the location and abundance of 
tpSTK1 within the ER and its phosphorylation of silaffin substrates in vitro, it is likely 
that tpSTK1 phosphorylates silaffins in vivo; therefore, tpSTK1 is regarded to be a 
silaffin kinase. TpSTK1 is the first structurally characterized kinase likely involved in 
biomineralization; and only the third kinase characterized that operates in the secretory 
pathway.  
 
4.2  On the ER residency of tpSTK1 
 
The exact location of tpSTK1 within the ER is unknown since expression of GFP-
tagged tpSTK1, in vivo, has failed. The signal peptide of tpSTK1 targeted GFP to a 
chloroplast associated clamp-like structure (CLS), as did the signal peptide of a known 
ER resident protein, BiP. A structure similar to CLS, termed “blob”-like structure (BLS) 
located at the periphery of plastids, was observed by Kroth and co-workers in the diatom 
Phaeodactylum tricornutum
123-124
. BLS is an accumulation site for GFP-tagged nuclear-
encoded plastid proteins, which contain an N-terminal signal peptide for ER import but 
lack a functional plastid import sequence (import of nuclear encoded proteins into diatom 
plastids proceeds through the ER, requiring a bipartite targeting sequence
120,125-126
). In 
diatoms, chloroplasts are tightly surrounded by the rough ER (termed CER)
119
. Therefore, 
CLS and BLS may represent subcompartments where ER-imported proteins transit before 




depleted membranes, it is likely that mature tpSTK1 may not reside exclusively in CLS (, 
see Figure 3.22), but mainly in different regions of the ER. As the intracellular location of 
GFP-tagged tpSTK1 could not be confirmed with microscopy, immunolocalization 
techniques such as immunofluorescence microscopy and immunogold electron 
microscopy could be employed to elucidate the precise location of tpSTK1 within the ER.  
TpSTK1 does not contain a C-terminal ER retrieval signal (C-terminal DDEL in 
diatoms, (H/K)DEL in other organisms), leaving the mechanism of tpSTK1 retention in 
the ER speculative. One possibility is that tpSTK1 contains an unknown ER retention 
motif. The ER-localized proteins s-cyclophilin (found in most eukaryotes) and a protein 
disulfide isomerase from a family of non-classical PDI-related proteins (PDI-D) from 
Dictyostelium discoideum both lack common ER retrieval signals
127-128
. Instead, s-
cyclophilin contains a unique C-terminal extension (VEKPFAIAKE) and the D. 
discoideum PDI-D contains a 57 amino acid C-terminal domain (termed the D domain, 
hence the name PDI-D) for retention in the ER
127-128
. Such C-terminal ER retention 
motifs are not present in tpSTK1. Expression and localization of GFP-tagged truncations 
of tpSTK1 is required to identify the peptide segment of tpSTK1 responsible for ER 
retention.. 
Another possibility for retention of tpSTK1 in the ER may be that tpSTK1 does 
not contain an ER retention signal at all, but rather binds to other ER resident proteins 
(e.g. BiP and GRP94) that carry an ER retrieval signal. The retention of proteins in the 
ER by this mechanism has been observed in the thiol-mediated ER retention of Ero1α, a 
protein involved in protein disulfide isomerase oxidation
129
. The ER resident chaperone 




with Ero1α to prevent the secretion of Ero1α129. As Ero1α is an important protein in 
regulating oxidative protein folding (which occurs in the ER), the retention of this protein 
in the ER is critical for its function. If the retention of tpSTK1 in the ER is achieved by 
interactions with another ER resident protein, then it may be possible to capture these 
interactions and identify the tpSTK1-ER retaining protein using “pull down” methods 
and mass spectrometry. Using anti-tpSTK1 IgGs, immunoprecipitation can be employed 
to “pull down” tpSTK1and any bound proteins and the protein complexes analyzed by 
mass spectrometry. In the event that the tpSTK1-ER protein interaction is non-covalent 
or otherwise unstable, chemical crosslinking agents can be used to stabilize the protein-
protein interaction due the presence of two or more reactive ends that chemically attach 
to specific functional groups on the proteins (i.e. primary amine groups, sulfhydryls). In 
addition to finding the tpSTK1-ER retaining protein (if such a protein exists), the 
combination of these methods would also lead to identification of the in vivo substrates of 
tpSTK1, which should include the T. pseudonana silaffins tpSil3 and tpSil1L. 
 
4.3  Other Diatom Biomineralization Kinases 
 
TpSTK1 is likely not the only kinase that phosphorylates silaffins in vivo. In the 
antibody based inhibition assays, native tpSTK1 only accounted for 25 % - 30 % of the 
silaffin kinase activity in the ER membranes, and there seem to be silaffin kinases present 
in the Golgi membranes (see Figure 3.29). Furthermore, recombinant tpSTK1 
incorporated only 1-3 phosphates per silaffin molecule whereas native silaffins are 




specifically phosphorylated serine residues on rSil3 yet native tpSil3 also contains 
phosphothreonine in addition to phosphoserine (see Table 3.3 and Figure 3.16). To 
identify tpSTK1-related kinases, a BLAST
107
 search using the primary sequence of 
tpSTK1 against three diatom genome databases was performed. The closest sequence 
homologues of tpSTK1 are the three predicted kinases, pt45008 (GenBankTM accession 
number EEC49800.1) and pt32914 (GenBankTM accession number EEC50886.1) from 
P. tricornutum, and tp7188 (GenBankTM accession number ACI64649.1) from T. 
pseudonana. Preliminary analysis of emerging genome sequencing data from the diatom 
Fragilariopsis cylindrus revealed five predicted kinases that exhibit higher sequence 
similarity to tpSTK1 and the tpSTK1-like diatom kinases (e-values: 8e-45 to 5e-70) than 
to any other serine/threonine kinases from diatoms or non-diatom organisms. These data 
suggested that tpSTK1 and its diatom homologs might represent a novel family of 
kinases involved in unconventional cellular pathways like silica biomineralization.  
The only tpSTK1-like kinase from the diatom T. pseudonana is putative kinase 
tp7188, herein referred to as tpSTK2. Given its high primary sequence homology to 
tpSTK1 (~ 40 % identical), this kinase may also be involved in the phosphorylation of 
silaffins
97
. However, recombinant tpSTK2-KD was unable to phosphorylate recombinant 
silaffins or recombinant silacidin in vitro (see Figure 3.19). In the antibody-based 
inhibition kinases assays, native tpSTK2 apparently did not account for any of the 
phosphorylation activity on recombinant silaffins or recombinant silacidin from the ER 
and Golgi membrane fractions (see Figure 3.31). Taken together, these data suggested 




tpSTK2 cannot be completely ruled out as a diatom biomineralization kinase for the 
following reasons:  
1.) The recombinant version of tpSTK2 that was expressed here (tpSTK2-KD) 
covered only of the kinase domain. The full length tpSTK2 may contain additional 
substrate recognition sequences that are not present in recombinant tpSTK2-KD.  
2.) The anti-tpSTK2-KD antibodies used for the inhibition assay with Golgi 
containing membranes may not efficiently inactivate native tpSTK2.  
3.) Native tpSTK2 may only act on substrates after they have been 
phosphorylated by other kinases or require the presence of other posttranslational 
modifications (e.g., alkylation of lysine residues, glycan moieties).
 
The requirement for 
existing phosphorylation appears unlikely, because tpSTK1 was unable to phosphorylate 
recombinant silaffins that have been phosphorylated bytpSTK1. 
4) TpSTK2 may phosphorylate hyrdoxyamino acids (e.g. hydroxyproline, 
dihydroxyproline) that are not present in the E. coli expressed recombinant silaffins. This 
presumption stems from the identification of phosphorylated hydroxyproline in the 
silaffin natSil2 from the diatom Cylindrotheca fusiformis
60
; similar phosphorylations on 
rare amino acids may also exist in T. pseudonana silaffins.  
In addition to the tpSTK1-like kinases identified in the genomes of other diatoms, 
there are other putative kinases that may phosphorylate silaffins and/or silacidins. In a 
whole genome expression profiling study of T. pseudonana under different nutrient-
limited conditions by Mock and coworkers, more than 10 genes encoding for putative 
kinases (not related to tpSTK1) showed expression patterns similar to that of tpSil3
91
. 




formation using whole-genome microarray analysis on synchronized T. pseudonana cells 
(unpublished data) revealed another six putative kinases, different from the 10 putative 
kinases in the Mock study, that may phosphorylate silaffins and/or silacidins. GFP-tagged 
variants of these candidate kinases could be expressed in T. pseudonana to determine 
their intracellular location via fluorescence microscopy. As evident by the kinase activity 
observed from ER and Golgi membrane fractions on recombinant silaffins and 
recombinant silacidin, and the presence of O-linked glycosylations on native silaffins, 
diatom biomineral forming proteins enter the secretory pathway via an ER targeting 
signal sequence and become modified within the endomembrane system (i.e. ER and 
Golgi) before reaching the silica deposition vesicle (the within which membrane bound 
organelle where silica deposition occurs)
48
. Therefore, using fluorescence microscopy to 
determine the intracellular location of these kinases would be a quick screening method 
to identify those that reside within the endomembrane system making them interesting 
candidates for silaffin and/or silacidin phosphorylation. Furthermore, using the 
biochemical methods (i.e. differential centrifugation, sucrose density gradient 
centrifugation) established in this study, a proteomic analysis of the ER and Golgi 
membrane fractions can be used to identify any membrane associated kinases that 
phosphorylate biomineral proteins. The proteomic study of the ER and Golgi membrane 
fractions may also lead to the identification of other proteins such as glycosyl and methyl 
transferases, peptidases, and hydrolases that posttranslationally modify silaffins. 
It should be noted that the majority of the silacidin phosphorylation activity was 
observed predominantly in the Golgi fractions, along with the majority of casein kinase 
activity. In addition, the sequence analysis program NetPhosK 1.0
131




putative casein kinase phosphorylation sites in recombinant silacidin, with greater than 60 
% probability for many of the sites. Though purely speculative, there may exist kinases 
analogous to the hydroxapatite biomineralization kinases found in mammalian ER and 
Golgi fractions
74-76
 that are involved in phosphorylation of the diatom biomineralization 
protein, silacidin. A search of the diatoms T. pseudonana and P. tricornutum genome 
databases
85-86
 for casein kinases revealed 15 putative kinases (tp38011, tp22118, tp21996, 
tp17468, tp17208, pt11285, pt14627, pt12614, pt7026, pt48012, pt54091, pt42322, 
pt21821, pt51110, and pt4216) with significant sequence similarity (e values < 2e-10) to 
more than 40 proven or predicted casein kinases from a broad range of organisms 
(including other biomineralizing organisms). There were no putative N-terminal signal 
peptides predicted for any of the putative kinases by the Signal P program
109
 nor was the 
C-terminal ER retention signal DDEL present in any of these sequences. However, ~ 75 
% of the casein kinase-like protein sequences appeared to be incomplete.    
 
4.4 Assessing the Importance of Diatom Biomineralization Proteins 
 
While the in vitro characterization of ER and Golgi kinases from diatoms, 
including tpSTK1, may implicate them in diatom biomineralization, the function and 
importance of these proteins in vivo may differ. Unfortunately, methods typically used to 
determine the role of a particular protein in vivo (i.e. gene knockdown or gene knockout) 
have yet to be established in the diatom T. pseudonana. However, there are alternative 
methods. 1) Biomineralization kinases can be (presumably specifically) inhibited in vivo 




them may be a great inhibitor of tpSTK1 activity (as judged by low IC50 values and 
kinase specificity). Also, if there are hydroxyapatite biomineralization-like kinases 
present in diatoms that are indeed isoforms of casein kinases I and II, then these kinases 
can specifically be inhibited by the compounds D4476 and IQA, respectively
132-133
. In 
addition to chemical inhibition, antibody based inhibition has been used to suppress the 
activity of a protein
42,72
. In this study, anti-tpSTK1 IgGs inhibited tpSTK1 kinase activity 
on recombinant silaffins in vitro. 2) Another approach for determining whether tpSTK1 
(or other future diatom biomineralization kinases) phosphorylates biomineral forming 
proteins in vivo take advantage of the established genetic manipulation techniques for T. 
pseudonana. TpSTK1 mutants (such those with an altered ATP binding site) could be 
generated and introduced into T. pseudonana to compete with the endogenous protein for 
substrates, or tpSTK1 can be overexpressed in the cells. Regardless of the approach used, 
it would be interesting if the any of these experiments result in a change in the degree of 
silaffin (or silacidin) phosphorylation that would cause a phenotypic change in the 









































Figure A.1 Amino acid sequences of recombinant silaffins. Hydroxyl amino acids 

















































































































































































































































































































































Figure B.1. Mass spectrum of recombinant silaffin rSilC. The expected molecular 
mass is 17.625 kDa. The observed molecular mass of 17.494 kDa corresponds to the loss 






















































































































































































































































































































































































Figure B.2. Mass spectrum of recombinant silaffin rSil3. The molecular mass that is 


















































































































































































































































































































































































































































































Figure B.3. Mass spectrum of recombinant silaffin rSil1L. The expected molecular 
mass is 11.8 kDa. The observed molecular mass of 11.667 corresponds to the loss of the 













































































































































































































































































































































































































Figure B.4. Mass spectrum of recombinant silaffin rSilN. The expected molecular 
mass is 9.978 kDa. The observed molecular mass of 9.799 kDa corresponds to the loss of 





APPENDIX C: tpak1 GENE SEQUENCE 
 
1    ATGACAGCTACACCGTATAACAGGGAGGAAGTGCAGAGGAGCCTTCGTGAAAAGTAAGTGTCGACAAACA 
      M  T  A  T  P  Y  N  R  E  E  V  Q  R  S  L  R  E  K   
   
71   GCGAATGAGCAGTATCCTATCAAGGTGTGGTCGCCGGTAGACGAGGACAAGCCTCGCGTGTGAACGCTTT 
 
 
141  TCGTGGTCTTTATTTCGCCCATTGCTCAAGGTGCCCTGTTGCTACTTCTATGCTTCTGTTCTCAGAATCT 
                                                                        I   
 
211  GGAGAGCTGCTGCCACGGCCGTATCAGAGGAAGATCCATGGAAGAAACATGACATAACATCAATCCCTGG 
     W  R  A  A  A  T  A  V  S  E  E  D  P  W  K  K  H  D  I  T  S  I  P   
 
281  TGAGTACTGATTGTATTCCACTCTTGCTCTACCTACAACAAACTTTTTCTAACATGGTCTCTTGCGTTGC 
 
 
351  TCACAGCCGAACGTGTAGTTCGACACTGTTACAACCCCAACACTCGCCAGTTTAAAAAGGATGAGACGAG 
           A  E  R  V  V  R  H  C  Y  N  P  N  T  R  Q  F  K  K  D  E  T   
  
421  TGAGTTCATCAGTTTAAGGCAATGTATCAATTGCAATTGTATTATGGCTTTATCACATATTATTCACTCC 
 
 
491  TTGTTGGACTAACAGTCGTCAAGGTGGAGAAGGAACCTTTCACTCACGGGGCGATGCGACATTGTTTCAG 
                    I  V  K  V  E  K  E  P  F  T  H  G  A  M  R  H  C  F  R 
  
561  ATTGAAGAAGCTAGCAACTCCACCACAATCATCATCCAACCATCGATTCCACAGTTATGGATGGAGTAGG 
       L  K  K  L  A  T  P  P  Q  S  S  S  N  H  R  F  H  S  Y  G  W  S  R  
 
631  GCGTTGAACTATGTTGCAAAGTGCTATCTAAAAGAAGACGGGACAATCGATACGAGCCGAAAGGGAACAG 
      A  L  N  Y  V  A  K  C  Y  L  K  E  D  G  T  I  D  T  S  R  K  G  T   
 
701  ACAACGTACTGACGGATATTATTCTACAATACGAAGCTGCCCATTGGTCGGCCCTCTTTAACGAAGCTAA 
     D  N  V  L  T  D  I  I  L  Q  Y  E  A  A  H  W  S  A  L  F  N  E  A  N 
  
771  TCCTCCTAGAAAGATTGATTTCATTAGAGCTTATGCCATGGAGTTTGTGGATCGTCCAGGCAAACCAATG 
       P  P  R  K  I  D  F  I  R  A  Y  A  M  E  F  V  D  R  P  G  K  P  M  
 
841  TTTGCAGTTGAGCGCTACATTGCGGGGAACGATAGCTACGGATGTGGTTTCCACAAACACAATACCAACT 
      F  A  V  E  R  Y  I  A  G  N  D  S  Y  G  C  G  F  H  K  H  N  T  N   
   
911  CTGGTTTCATTGACTTGGAGATACGCCGGAAGACTCCTCAGGTGTTTTCAGCTCATAGCTTCTACGCTTC 
     S  G  F  I  D  L  E  I  R  R  K  T  P  Q  V  F  S  A  H  S  F  Y  A  S 
 
981  GGAAGGGACGAGACTCGTTGCAGATGTTCAGGGCGTGGGAGATCTTTATACTGATCCGCAGGTGCTATCC 
       E  G  T  R  L  V  A  D  V  Q  G  V  G  D  L  Y  T  D  P  Q  V  L  S  
 
1051 ATTGACTATCGCTTTGGTGACGGAGATCTCGGCCCTAGAGGAATGGCTTTGTTCTTCAAAACCTTTCGTC 
      I  D  Y  R  F  G  D  G  D  L  G  P  R  G  M  A  L  F  F  K  T  F  R   
 
1121 ATTGTGATATGAGCGACCTTCTGGGGATTCCAATCTTTCCACTATCAAGAAATGAACGTCGCCACCAGGC 
     H  C  D  M  S  D  L  L  G  I  P  I  F  P  L  S  R  N  E  R  R  H  Q  A 
  
1191 TAAATACGATGACGAAGAAAGCACTTTAAGTGAAGCGTCATCTGCTGTAGAGGAAGATCTAAGGTGCAGA 
       K  Y  D  D  E  E  S  T  L  S  E  A  S  S  A  V  E  E  D  L  R  C  R  
 
1261 TTCAAGATGCTAGATGCCAATAGGCAACGGAGGAAAACAGTCTTAATGAGACCGATTGACATCATGCAAT 






     S  E  D  K  A  D  T  A  K  R  S  N  I  S  N  V  S  L  T  I  R  Q  S  M 
  
1401 GAGACAACTGAACATACAAAAGTCAGTGATTCATCGTTCAAAATCGGATGTCGATGAGATCACATCCTGC 
       R  Q  L  N  I  Q  K  S  V  I  H  R  S  K  S  D  V  D  E  I  T  S  C  
 
1471 TTGCAAATGGCAGTGACTGATGCGGTATTTGATCACACAGCGTTTCATAGATACGAATCTGGAGAACTGA 
      L  Q  M  A  V  T  D  A  V  F  D  H  T  A  F  H  R  Y  E  S  G  E  L   
   
1541 AACCTCGTCACTTCCACGGGACACCGAAGCATCAAACTCAGTTAACCGTGGTACCAGTGAAAGCATCGCC 
     K  P  R  H  F  H  G  T  P  K  H  Q  T  Q  L  T  V  V  P  V  K  A  S  P 
  
1611 GCCAATGAAGATAACTGACGAGACAAAGGCAAATCTCGGCAAAGTAAGTATTGTATCGCGTTATTGGCAT 






          V  H  Y  H  L  A  C  L  H  G  L  D  R  F  P  E  I  V  P  T  N  A  
 
1821 TCCTCTGGCGTGGAGGATCTTCCCAGCCATGATGTCTTCTCTGTGGTGTTTCATCTCTCTCATGCAGCGT   
      S  S  G  V  E  D  L  P  S  H  D  V  F  S  V  V  F  H  L  S  H  A  A   
 
1891 CACTCTACAACGTACCAGCTTGTCTCTCATTGGCTCGTGCTCTAATTGGCCTTGATAGCTCGGTATCTCC 
     S  L  Y  N  V  P  A  C  L  S  L  A  R  A  L  I  G  L  D  S  S  V  S  P 
 
1961 TTTGCTCAAAGCGAACGTCCGTATTGATTTTGAGCTATCAAAGGATTTGTGCTGGCGAGGGATGACTGCT  
       L  L  K  A  N  V  R  I  D  F  E  L  S  K  D  L  C  W  R  G  M  T  A  
 
2031 CAAAAGGCCCGTGCTGCTCCGAAAGTTGCGGCTGGTTGTTTGTTGTATCAAATCCTTGAAGACGAAGGTA 
     Q  K  A  R  A  A  P  K  V  A  A  G  C  L  L  Y  Q  I  L  E  D  E  G   
 
2101 CAACAGGCGATGTAGAAAAGATGAACATTCTAGAGGAGACGCTGAACCAGATGAAAGTTGCTACCGAAGA  
     T  T  G  D  V  E  K  M  N  I  L  E  E  T  L  N  Q  M  K  V  A  T  E  E 
 
2171 GGAAGCCATTTTGAAGGAGCATGCAAACAAATTAACCCGAGGTAAGGCCGCAGGCTTCCACGTGGGCGAC 
       E  A  I  L  K  E  H  A  N  K  L  T  R  G  K  A  A  G  F  H  V  G  D  
 
2241 AAAGTGGAAGGAAACTACTTCATGGAAGGAACATTCTACAGTGGAGTTGTGGTTGAAGTTCTCGATGGTG 
     K  V  E  G  N  Y  F  M  E  G  T  F  Y  S  G  V  V  V  E  V  L  D  G   
 
2311 GCAACTCTGTTGTGGTTCAATACGACGACGATGGATCGGCTGAACAATTGACGATTGACAATGTCCGCTC  
     G  N  S  V  V  V  Q  Y  D  D  D  G  S  A  E  Q  L  T  I  D  N  V  R  S 
 
2381 TATTGAACCTGCAACGGCCATTACTGATGATCAGAACTCTCCCTTGTCAGATGAAGAAGCATTGGGCAGC 
       I  E  P  A  T  A  I  T  D  D  Q  N  S  P  L  S  D  E  E  A  L  G  S  
 
2451 GTTAACACTGATGAAGAGTGCTTGTTTGAAGACTATGAGTTGATGGCTAAACTCGCGGACTTGAAAGTGA   
      V  N  T  D  E  E  C  L  F  E  D  Y  E  L  M  A  K  L  A  D  L  K  V   
 
2521 AGGCTGGAAAGCGAAACGATGCGCGGGTGCTATATCAGGATGCAGCAGAGCTTGCCATGTCTGCGGGTAA 
     K  A  G  K  R  N  D  A  R  V  L  Y  Q  D  A  A  E  L  A  M  S  A  G  K 
 
2591 GATGAAGACGGCGAATTGCTTGAGTATGAAGGCCGCCCAACTTGAAGGTTAG 
       M  K  T  A  N  C  L  S  M  K  A  A  Q  L  E  G  *  
 
 
Figure C.1 DNA sequence of the tpak1 gene. Introns are indicated in grey italics. The 

























Figure D.1 Amino acid sequence of recombinant tpAK1. The C-terminal hexahistidine 




















Figure E.2. Recombinant tpAK1 phosphorlation activity. SDS-PAGE analysis of recombinant 
tpAK1 phosphorylation activity in the presence of [γ-
32
P]ATP using recombinant silaffins (rSilN, 
rSilC, rSil3, and rSil1L) and commercial proteins as substrates. Lys.- Lysozyme, His-Histone, 














APPENDIX F: tpstk1 GENE SEQUENCE 
 
 
   1 ATGAGAGTCATACGCAATGTTTCTCTCGTAGTCATCGTCACGTCATGCACCTTTCTTGTGTCCGTCACCT 
      M  R  V  I  R  N  V  S  L  V  V  I  V  T  S  C  T  F  L  V  S  V  T   
 
  71 CCTTCACATCACAACGCACCGTCACCTCGGCATCTCCATCCTACACCAACTCAAACAACAATCTCTACTC  
     S  F  T  S  Q  R  T  V  T  S  A  S  P  S  Y  T  N  S  N  N  N  L  Y  S 
 
 141 GCCACCGCTCTTTGCATCAGGTCCACCCGTTATCAGCAACTGGCGTTACCAATCCTCTTCTGGTACCATT  
       P  P  L  F  A  S  G  P  P  V  I  S  N  W  R  Y  Q  S  S  S  G  T  I  
      
 211 TCAGGAACAGTCACAAACCATCCCACCATTCCTGATGGAGACAGTATCACTACGTCACCAGTGAGGGATG  
      S  G  T  V  T  N  H  P  T  I  P  D  G  D  S  I  T  T  S  P  V  R  D   
        
 281 GAAATGGCATCAACGAGAATACAATAGTGCAGACGAAGAGTGGGAGCAAGTATAAGTTGAGCAATGTTGC  
     G  N  G  I  N  E  N  T  I  V  Q  T  K  S  G  S  K  Y  K  L  S  N  V  A 
       
 351 TTGGGGAGCGACGATTCCTGCAGTGGAGACGAAGAAGGCGATGCAAAAGGAAGCTGAGGCTGCCGAGAAG  
       W  G  A  T  I  P  A  V  E  T  K  K  A  M  Q  K  E  A  E  A  A  E  K  
      
 421 GCGAGGAAGGTCGAGGCGGAGAAAGCAAAAACTGCAGCTGCCAAGGCGAAAACAGCATCCAAAGCAACAC  
      A  R  K  V  E  A  E  K  A  K  T  A  A  A  K  A  K  T  A  S  K  A  T   
 
 491 CAAAAGCAACATCACCGGCTGCAGCTACTACCAAACAACCATCCTCTGCAGAACTGCGTCGACTTGCCAA  
     P  K  A  T  S  P  A  A  A  T  T  K  Q  P  S  S  A  E  L  R  R  L  A  K 
 
 561 ATCAACATTCTCTCTCACCGGTAACACAGTCGGCTCCAACGGGAAATACCTCCTCGCAGGCAAACCCCGT  
       S  T  F  S  L  T  G  N  T  V  G  S  N  G  K  Y  L  L  A  G  K  P  R  
      
 631 CAATCTTCCGGCAGAGCTGCCAAAATCTGGACTGCGTACATTGCCGACCCCATCGAGCCTGGAGTACCAC  
      Q  S  S  G  R  A  A  K  I  W  T  A  Y  I  A  D  P  I  E  P  G  V  P   
        
 701 TTGGTTTTAGCGAGGGAGACGAGTCAAAAGTACAACCACTCACAATCAAATTAAGTCCAGATGTCGATAG  
     L  G  F  S  E  G  D  E  S  K  V  Q  P  L  T  I  K  L  S  P  D  V  D  R 
 
 771 ATTGTACTTGGAGAATGCAAACTACAACAAAGTTCAATCGGGATTGTTCATGGGGAGATTTGTAAAGAAG  
       L  Y  L  E  N  A  N  Y  N  K  V  Q  S  G  L  F  M  G  R  F  V  K  K  
 
 841 ATGGACTACATTGAGAATGTACCATCGAGCGATCGTTCTTTGGATGGGAAAGTGTCAGCTTTAATTATTG  
      M  D  Y  I  E  N  V  P  S  S  D  R  S  L  D  G  K  V  S  A  L  I  I   
 
 911 AGTCGGGGCAATATGATCTCAAGGCGTTGTTGTCGGCGAGGAAGGGACTTCCCTTGGCAGGGAAAGCATT  
     E  S  G  Q  Y  D  L  K  A  L  L  S  A  R  K  G  L  P  L  A  G  K  A  L 
 
 981 GAGGGATGCCGCAGCTGCAGCAGGGCAGTGCATCCAAGCAGTACATTCCAGCAACCTCGTTTGGACTGAT  
       R  D  A  A  A  A  A  G  Q  C  I  Q  A  V  H  S  S  N  L  V  W  T  D  
      
1051 TTGAAGACGGAGAATTTCATTGTCGTGCGGAACGGTAACTTGTATCAAGAAGTGGAGGATGTCAAAGGTT  
      L  K  T  E  N  F  I  V  V  R  N  G  N  L  Y  Q  E  V  E  D  V  K  G   
 
1121 CAATGGGGCTGCCTGGAGTGAAGGGCATTGATTTGGAGTCAGTGATTGCCAAGGGGGGCAATCCAATCGA  
     S  M  G  L  P  G  V  K  G  I  D  L  E  S  V  I  A  K  G  G  N  P  I  D 
       
1191 CTACTCGCCCGAGGCATGTCCTCCAGAGTTTGCCAAAGCGTACATGGAAGGAATCGGGGGTGATTTCGTC  
       Y  S  P  E  A  C  P  P  E  F  A  K  A  Y  M  E  G  I  G  G  D  F  V  
 
1261 TTGGACTATTCATACGATATGTGGAGTCTGGGAATGATGCTGTACGAACTTTCCACTGGCAAAGCATACT  
      L  D  Y  S  Y  D  M  W  S  L  G  M  M  L  Y  E  L  S  T  G  K  A  Y   
 




     F  D  K  K  G  P  S  Q  V  T  K  L  L  C  T  D  T  F  E  A  D  V  S  A 
 
1401 TGTGCCTGATGAAAAGTTACGAGATTTGATTGGGAACTGCTTGAACTTGGATCCTCGAAAGCGACCGGAC  
       V  P  D  E  K  L  R  D  L  I  G  N  C  L  N  L  D  P  R  K  R  P  D  
 
1471 ATTACTGGATTCTTGTTGCATCCGTACTTTCTTCTCAGCGGCATCGGTCCTATCAGCTTTTAG  





Figure F.1 DNA sequence of the tpstk1 gene. The deduced amino acid sequence 






















































Figure G.1 Amino acid sequence of recombinant tpSTK1. The N- and C- terminal 
hexahistidine tags are indicated in blue. The spacer region is in bold and the rTEV 




APPENDIX H: SILACIDIN AMINO ACID SEQUENCE 
 
 
         
 1  MVKYNVLAFIAVLGVSLINTSSA 
 
24  KTSLRGHRQLAKPEKLGNANTSYALGSSINKVRRL  
  
58  SSSEDSGDSPPSDESEESEDSVSSEDEDRRL            Silacidin A 
 
89  SSSEDSGDSPPSDESEESEDSVSSEDEDRRL            Silacidin A 
 
120 SEDSVDSLPSDESEESEDSVSSEDEDRRL               Silacidin C 
 
149 SEDSGDSLPSDESEESEDSVSSEDEDRRL               Silacidin B 
 
178 SSSEDSGDSPPSDESEESEDSVSSEDEDRRL          Silacidin A 
 
209 SSSEDSGDSPPSDESKESGDSVSSED                      Silacidin A 
 
 
Figure H.1. Amino acid sequence of silacidin. The spacer sequence RRL between 
individual silacidin repeats (Silacidin A, B, or C) is shown in green. Hydroxyl amino 

























Figure I.1. Amino acid sequence of recombinant rSilNH10rSic fusion protein. The 
methionine between rSilNH10 and rSic is shown in green bold. The decahistidine tag is 





















1    ATGCCCTTCTGTGGCAGGTGGATTGCAAGCTACTACTCACCTTGTGTTCCATCTCGCCCTACGCATGAGT  
      M  P  F  C  G  R  W  I  A  S  Y  Y  S  P  C  V  P  S  R  P  T  H  E   
   
71   GGGCTGCAGCCGACAAGAACTTTCAACTGGGCCGGTTAACTACGGACGAAAAGGCAGGCATTACATCAGT  
     W  A  A  A  D  K  N  F  Q  L  G  R  L  T  T  D  E  K  A  G  I  T  S  V 
 
141  TCGCACGAAAGATGATTGGGTAGAGAATTACGTCTCTCAAACGGTTGCGACTCGTATCGAGAGGGAAAGA  
       R  T  K  D  D  W  V  E  N  Y  V  S  Q  T  V  A  T  R  I  E  R  E  R  
 
211  GCTGATGGCAATCGTCACTTCTACAAAAACAAAGACTGCCAAGAAGCCTTTGCTCGCTTCACGTGTTGGT  
      A  D  G  N  R  H  F  Y  K  N  K  D  C  Q  E  A  F  A  R  F  T  C  W   
 
281  AAGTCAGCTACAGTGTGCATTAAGTGAAGAAGTTGCTGTTGTTGTTGTTGTTGTTGTTGTTGTTTCCTTG  
 
 
351  TGTTGCAACCTGATCTTTCTTTCGTTGTTCTTCCAAAGGCTCAACTTCCCTCGTTGTGACGAACGATTTG  
                                          R  L  N  F  P  R  C  D  E  R  F   
 
421  AAGAGTCGCTACCTCTTTGCCGTTCCGCTTGTGAAAATATATTTCGAGTATGTGGCTTTGAGAATGATCT  
     E  E  S  L  P  L  C  R  S  A  C  E  N  I  F  R  V  C  G  F  E  N  D  L 
 
491  TTGGAGATGTGAAGAAGATGTGATTGATGGCAATGACGAGTACGATCTGAGAGGATTCTTTCCAGGACAG  
       W  R  C  E  E  D  V  I  D  G  N  D  E  Y  D  L  R  G  F  F  P  G  Q  
 
561  CCGTTCAAGAGGAATGAGTTCTTTCCAAAGAGCAACGGAGAGCCAAAGGCAGTTTGTACTCCTAGTATCA  
      P  F  K  R  N  E  F  F  P  K  S  N  G  E  P  K  A  V  C  T  P  S  I   
 
631  AAGGCTCGGCACCTTCACGATACGGTGGTGTTGCGTTTGTGGCCGTGATTGGTATCAATGCGATGCTAGT  
     K  G  S  A  P  S  R  Y  G  G  V  A  F  V  A  V  I  G  I  N  A  M  L   
 
701  ACTTAGTCTTTGCTCTACCGTTTAGACTCAACATGTATTAGCTACTAGCACGTAATGATCAATCTACTAT  
 
771  TGAATATGAGATTTATCTCGTTTCGTAACTCAAGAAATGAGTTCGAGATTACTGTGCACTTCACCTCCAA  
   
841  ACAATGAGTGTGACGAGCGACGTTTGAACTAGAAGTCAAAGTGATTCCAATAAGTACCAGTATCTGTGAC  
 
911  CTACCATAAAGGATTCTTGATCTTTATGGTATCCGTATATTCATGATCGAAGGCAAGCTAGGTAAATCCA       
 
981  ACAGTATTAACTCATCGTAGTGTGAATTGAATATGGTGCAATGACATCGACGTAGCTAGTGGTGCAACGT  
 
 
1051 CGGTGAGAAGAGAGAGGGTGCGTATCCGTTTGATAGTTTGTTAGTAATCTCCTTCAATCACAATCCTCAA  
 
1121 CCAACTCGAAGCCGAATCGAAGCGAAGCGCTTGGAACCATGGCAAGGCGTGGCCTTGCAATAAGCTTGAT  
 
1191 ATACATCTTTCATACAGTCTCATTCACACAGTCATTGATACCATCCTCGCGCTATTGGGTAGGTGACATA  
                                     S  L  I  P  S  S  R  Y  W  V  G  D  I  
 
1261 GGCAAAAGTAGAGACACAACTACCCCAACCACAACATCATCAAACCATCACCTGTACCAACGACGACACC  
      G  K  S  R  D  T  T  T  P  T  T  T  S  S  N  H  H  L  Y  Q  R  R  H   
 
1331 AATCATCAAGAACAAAACTCTCTGCCTTCTTCCTCAACGACAAAGACGACAATAACAAGACGCCTTCCAA  
     Q  S  S  R  T  K  L  S  A  F  F  L  N  D  K  D  D  N  N  K  T  P  S  K 
 
1401 GAATAATGCTACGCCATTGGGGAAGGACGGCTCCTCTGCCAACGCAGACCTCCTCCAAACACTAGAGCTA  





1471 AAAGATGAAGCCCTCTACCAAGCACAAACGGCGGTGTCAAGTCTCGAGAAGGCACTGGAATCTGCTGTTA  
      K  D  E  A  L  Y  Q  A  Q  T  A  V  S  S  L  E  K  A  L  E  S  A  V   
   
1541 CGAATTTAGAGAATATGCAACAGCAGTTGCAATTACGGGTGCTTCGTTTGGAGAAGGAATTACGTACTAC  
     T  N  L  E  N  M  Q  Q  Q  L  Q  L  R  V  L  R  L  E  K  E  L  R  T  T 
 
1611 CAAGGGTGAATTGACTGATACGATGGGAGAATTACAAAAGACACGGACAGAGTTGCAAAGTACGAGAGAG  
       K  G  E  L  T  D  T  M  G  E  L  Q  K  T  R  T  E  L  Q  S  T  R  E  
 
1751 GAGTTGACACAATCGAGAGAGGAACGTGATGGGTTGGACTGGGCATTGGGACAGAGTCAAGAGGGGCAAC  
      E  L  T  Q  S  R  E  E  R  D  G  L  D  W  A  L  G  Q  S  Q  E  G  Q   
 
1821 AGAAGGCGGAGACAAGGGTGGAGGAGCTGGAGACGTATTTGGCTACGTTGGGGGTGGACGCTGAGACTAT  
     Q  K  A  E  T  R  V  E  E  L  E  T  Y  L  A  T  L  G  V  D  A  E  T  I 
 
1891 TACTGCGAAGAAGAAGGTCGAGGTTAGTGTGATTACTCATACAAGTGTGTTCAGATTGCGATTGACTTGT  
       T  A  K  K  K  V  E   
 
1961 CTTACCACTTGACTTCCTGTTTCATTTAGTCAAATCCATGGCAACTGTGGCCGGGGAACTCAAAAACGTC  
                                   S  N  P  W  Q  L  W  P  G  N  S  K  T  S 
 
2031 TGTACCAGTACTGAACGATTGGGTAGTAATCAACGGAAGTATCGAGGGAGAGGTTCAAATCTCTGGAAAA       
       V  P  V  L  N  D  W  V  V  I  N  G  S  I  E  G  E  V  Q  I  S  G  K  
 
2101 GTCACAAACCACCCTTCCATTCCCGACGGAGATGCCATTGTCACTAGTCCTTTATCGGATGCAACCCAAG         
      V  T  N  H  P  S  I  P  D  G  D  A  I  V  T  S  P  L  S  D  A  T  Q   
 
2171 TAGCAGAAAAGAAGATTGTTTCAACCTCATCTGGATCAAAATACAAGCTTGGAAAGCCAATGGATATGCC  
     V  A  E  K  K  I  V  S  T  S  S  G  S  K  Y  K  L  G  K  P  M  D  M  P 
 
2241 GGCAAATCAATCTCCATCCAAGTACGTAGGCGGGGGGAAAGGTAGCAATTCACAGCAATACTCAGGATCA  
       A  N  Q  S  P  S  K  Y  V  G  G  G  K  G  S  N  S  Q  Q  Y  S  G  S  
 
2311 CGAGCCAGTATTGCACTTCCAGACCTGACTGGTAAAACTATCGGCAATGGACGCTATCTCCTAGCAGGTC  
      R  A  S  I  A  L  P  D  L  T  G  K  T  I  G  N  G  R  Y  L  L  A  G   
 
2381 CTGCAACACCTAGTGTGAATGGAAGGAGTTTCATACAAACTGCATACCGATCCACTCCTGTTGGCAAACC        
     P  A  T  P  S  V  N  G  R  S  F  I  Q  T  A  Y  R  S  T  P  V  G  K  P 
 
2451 GATTGGCGAGCCACTGGCTATCAAAGTATCGCAAAACAAGGAAGCAATGAAACGTGAGTTTGCCAATTAT  
       I  G  E  P  L  A  I  K  V  S  Q  N  K  E  A  M  K  R  E  F  A  N  Y  
 
2521 CAAAAGGTATCAGCAGGCTTGAAGAAGGGGCACTTTATTCGAAGAAATGAGTTTCTACCTGTGGCTGGGA        
      Q  K  V  S  A  G  L  K  K  G  H  F  I  R  R  N  E  F  L  P  V  A  G   
 
2591 ATGAAATGCCTGACAAGAGTGCGTTGGTGATGCAACGGGGTGTGGCGGATGTCAAGGCGTTCATGCCAAA  
     N  E  M  P  D  K  S  A  L  V  M  Q  R  G  V  A  D  V  K  A  F  M  P  K 
 
2661 AGTAGGGGGAAGACTTGAGGGGGAAATGTTGATGGATTGTGCAGTGACCGCCCTCCGTTGTGTAGAAGCA      
       V  G  G  R  L  E  G  E  M  L  M  D  C  A  V  T  A  L  R  C  V  E  A  
 
2731 TTGCATGCTGTGAAGTTGGTGTGGAACGATCTCAAGACGGAGAATTTTGTTGTGATCGAGGACGGAGGTG  
      L  H  A  V  K  L  V  W  N  D  L  K  T  E  N  F  V  V  I  E  D  G  G   
 
2801 GTGTGTCGTTCCGAGGAATCGATCTGGAAAGTTGCATGACAGTCAGAACAAACCCAGTGGATTACACTCC  
     G  V  S  F  R  G  I  D  L  E  S  C  M  T  V  R  T  N  P  V  D  Y  T  P 
 
2871 AGAAGCATGTCCACCAGAGTTTGCTCAATCATTCCTGGACGGAGATGCAGAGTCGTTCCTTTTAGAGTAC  
       E  A  C  P  P  E  F  A  Q  S  F  L  D  G  D  A  E  S  F  L  L  E  Y  
 
2941 TCGTATGACGTATGGAGTTATGGAATGTTCCTCTATGAGATTAGCACCGGTCGTGGCTTCTTTGATGGTT         





3011 ACTCAGCGGAGAAAATCACAAAACTGCTTCCATCTTTTGAACCGGACGTGAGTCAAGTACCCGATGCACA  
     Y  S  A  E  K  I  T  K  L  L  P  S  F  E  P  D  V  S  Q  V  P  D  A  Q 
 
3081 ACTAGCTGATTTGATTTTGCAGTGCTTGTCAAAGAACCCGAAAGATCGACCGTCGCTTGTCAGAATCGCA  
       L  A  D  L  I  L  Q  C  L  S  K  N  P  K  D  R  P  S  L  V  R  I  A  
 
3151 AAACACCCGTACCTCGCAAGTGCGACAGCGAGCAAGACTCCATTTGACTTCTTATTTGGATCATCCATCT  
      K  H  P  Y  L  A  S  A  T  A  S  K  T  P  F  D  F  L  F  G  S  S  I   
 
3221 AA     
     *  
 
 
Figure J.1 Predicted DNA sequence of the tpstk2 gene. Introns are indicated in italics. 
The deduced amino acid sequence appears below the DNA sequence. Sequences that 



































Figure K.1 Amino acid sequence of recombinant tpSTK2 kinase domain. The C-
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